Subsequent Events [Table]
Subsequent Events [Table]
Subsequent Events [Table]
Lease Liability
Lease liabilities [member]
Subsidiary Notes Payable
Subsidiary Notes Payable [Member]
Subsidiary Notes Payable
Not impaired [Line Items]
Not impaired [Line Items]
Not impaired
Percent, number of shares held
Percent, number of shares held
Percent, number of shares held
Restricted Share Units
Restricted Share Units (RSU) [Member]
Restricted Share Units (RSU) [Member]
Loss with respect to associate for which no deferred tax asset is recognized
Rate of loss with respect to associate for which no deferred tax asset is recognized, reconciliation of effective tax rate
Rate of loss with respect to associate for which no deferred tax asset is recognized, reconciliation of effective tax rate
Subsidiary operating companies
Subsidiary operating companies [Abstract]
Subsidiary operating companies
Share of other comprehensive income of associates and joint ventures accounted for using equity method that will not be reclassified to profit or loss, net of tax
Share of other comprehensive income of associates and joint ventures accounted for using equity method that will not be reclassified to profit or loss, net of tax
Income Tax Type [Axis]
Income Tax Type [Axis]
Income Tax Type
Cash Distribution
Cash Distribution
Cash Distribution
Property, plant and equipment
Disclosure of detailed information about property, plant and equipment [line items]
0.01
Exercise Price Range One [Member]
Exercise Price Range One [Member]
Security Exchange Name
Security Exchange Name
Gain/(Loss) from change in fair value of convertible debt
Gain/(Loss) from change in fair value of convertible debt
Gain/(Loss) from change in fair value of convertible debt
Disclosure of Subsidiary Preferred Share balances
Summary of Subsidiary Preferred Shares Balances [Text Block]
Summary of Subsidiary Preferred Shares Balances
Amortization of intangible assets
Amortisation expense
Amortisation expense
Executive Compensation
Executive compensation, reconciliation of effective tax rate
Executive compensation, reconciliation of effective tax rate
Goodwill
Goodwill
Cash paid for rent - interest
Cash outflow for leases
Entity Address, Country
Entity Address, Country
Maturity [axis]
Maturity [axis]
Leases
Description of accounting policy for leases [text block]
Investment, Name [Axis]
Investment, Name [Axis]
Tax Effected
Tax Effected [Member]
Tax Effected
Common Shares, value realised assigned to PureTech Health, LLC [Member]
Ordinary Shares, value realised assigned to PureTech Health, LLC [Member]
Ordinary Shares, value realised assigned to PureTech Health, LLC
Within Three Months
Within Three Months [Member]
Within Three Months
Non-Controlled Founded Entities
Non-Controlled Founded Entities [Member]
Non-Controlled Founded Entities
Average number of employees
Average number of employees
Gain/(loss) on disposal of assets
Gains (losses) on disposals of non-current assets
Income/(loss) attributable to:
Profit (loss), attributable to [abstract]
Entrega and Vedanta
Entrega and Vedanta [Member]
Entrega and Vedanta
Minimum liquidation preference
Minimum liquidation preference
Minimum liquidation preference
Accumulated amortization
Accumulated depreciation and amortisation [member]
Final fee, percentage of original principal amount outstanding
Debt instrument, payment terms, final fee, percentage of original principal amount outstanding
Debt instrument, payment terms, final fee, percentage of original principal amount outstanding
Weighted average grant date fair value, RSU vested (in GBP per share)
Weighted average grant date fair value of other equity instruments Vested in share-based payment arrangement
Weighted average grant date fair value of other equity instruments Vested in share-based payment arrangement
Disclosure Of Total Operating Expense
Disclosure Of Total Operating Expense Explanatory [Text Block]
Disclosure Of Total Operating Expense Explanatory
Subsequent Events [Line Items]
Subsequent Events [Line Items]
Subsequent Events
Disclosure of share capital, reserves and other equity interest [Abstract]
Disclosure of share capital, reserves and other equity interest [Abstract]
Operating Expense [Member]
Operating Expense [Member]
Operating Expense
Estimated fair value of the preferred share
Estimated fair value of the convertible preferred shares, measurement input [Member]
Estimated fair value of the convertible preferred shares, measurement input
Proceeds from maturity of short-term investments
Proceeds from sales or maturity of financial instruments, classified as investing activities
Financial instruments, class [member]
Financial instruments, class [member]
Other not including Vedanta [Member]
Other not including Vedanta [Member]
Other not including Vedanta
Leasehold improvements
Leasehold improvements [member]
Property and Equipment
Description of accounting policy for property, plant and equipment [text block]
Accounting Policies
Disclosure of significant accounting policies [text block]
Payment of lease liability
Cash paid for rent - principal - financing cash flow
Payments of lease liabilities, classified as financing activities
Disclosure of gain on deconsolidation
Disclosure of gain on deconsolidation [Text Block]
Disclosure of gain on deconsolidation
Financial Asset Increase/ (Decrease)
Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, assets
General And Administrative [Member]
General And Administrative [Member]
General And Administrative
Useful life measured as period of time, property, plant and equipment
Useful life measured as period of time, property, plant and equipment
Share capital [member]
Share capital [member]
Construction in progress [member]
Construction in progress [member]
Share capital
Issued capital
Borrowings, adjustment to interest rate basis
Borrowings, adjustment to interest rate basis
Effect of exchange rates on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents
Total current liabilities
Current liabilities
Current liabilities
Equity - Acquired Share capital PureTech LLC [Line Items]
Equity - Acquired Share capital PureTech LLC [Line Items]
Equity - Acquired Share capital PureTech LLC
Ensof Holdings, LLC (held indirectly through Enlight)
Ensof Holdings LLC [Member]
Ensof Holdings LLC
Disclosure of detailed information about borrowings [text block]
Disclosure of detailed information about borrowings [text block]
2018 Performance Based RSU [Member]
2018 Performance Based RSU [Member]
2018 Performance Based RSU
Other Financial Assets [Abstract]
Other Financial Assets [Abstract]
Weighted Average Options exercisable [Table]
Weighted Average Options exercisable [Table]
Weighted Average Options exercisable [Table]
Local Phone Number
Local Phone Number
Disclosure of liquidity risk
Disclosure of liquidity risk [text block]
Timing of transfer of goods or services [axis]
Timing of transfer of goods or services [axis]
Recognition of deferred tax assets and tax benefits not previously recognized
Tax Rate Effect of deferred tax assets and benefits not previously recognised
Tax Rate Effect of deferred tax assets and benefits not previously recognised
R&D and orphan drug tax credits
Rate of Research And Development and orphan drug tax credits, reconciliation of effective tax rate
Rate of Research And Development and orphan drug tax credits, reconciliation of effective tax rate
Expiring [Domain]
Expiring [Domain]
Expiring [Domain]
Merger reserve
Merger reserve
Tax losses and tax credits carryforwards [Line Items]
Tax losses and tax credits carryforwards [Line Items]
Tax losses and tax credits carryforwards [Line Items]
Disclosure of financial liabilities [line items]
Disclosure of financial liabilities [line items]
Associates [axis]
Associates [axis]
Trade and other payables
Adjustments for increase (decrease) in trade accounts payable
Number of shares issuable based on performance conditions
Number of shares issuable based on performance conditions
Number of shares issuable based on performance conditions
Share-based payments
Key management personnel compensation, share-based payment
Directors and Senior Managers
Directors and Senior Managers [Member]
Directors and Senior Managers
Increase Decrease In Number Of Shares Outstanding, Changes In Ownership Interest In Subsidiaries That Do Not Result In Loss Of Control
Increase Decrease In Number Of Shares Outstanding, Changes In Ownership Interest In Subsidiaries That Do Not Result In Loss Of Control
Increase Decrease In Number Of Shares Outstanding, Changes In Ownership Interest In Subsidiaries That Do Not Result In Loss Of Control
Loss with respect to associate for which no deferred tax asset is recognized
Loss with respect to associate for which no deferred tax asset is recognized , reconciliation of effective tax rate
Loss with respect to associate for which no deferred tax asset is recognized, reconciliation of effective tax rate
Going Concern
Disclosure of going concern [text block]
Transferred at a point in time – Licensing Income
Goods or services transferred at point in time [member]
Other
Other, non-controlling interest, equity
Other, non-controlling interest, equity
Gelesis, Inc.
Gelesis [Member]
Gelesis [Member]
Gelesis
Deconsolidation adjustments
Rate of deconsolidation adjustments, reconciliation of effective tax rate
Rate of deconsolidation adjustments, reconciliation of effective tax rate
Short-term note [Line Items]
Short-term note [Line Items]
Short-term note [Line Items]
Merged entity Gelesis and Capstar
Merged entity Gelesis and Capstar [Member]
Merged entity Gelesis and Capstar
Changes in the value of subsidiary preferred shares [Line Items]
Changes in the value of subsidiary preferred shares [Line Items]
Changes in the value of subsidiary preferred shares
Gains (losses) on financial assets at fair value through profit or loss, designated upon initial recognition or subsequently
Gains (losses) on financial assets at fair value through profit or loss, designated upon initial recognition or subsequently
Range of Exercise Prices (GBP)
Exercise Price Range $
Exercise price of outstanding share options
Entity Well-known Seasoned Issuer
Entity Well-known Seasoned Issuer
Interest Expense
Rate of interest expense, reconciliation of effective tax rate
Rate of interest expense, reconciliation of effective tax rate
Disclosure of changes in financial liabilities - Warrants
Disclosure of financial liabilities - Warrants [Table Text Block]
Disclosure of financial liabilities - Warrants
Tenant improvement - lease incentive
Tenant improvements, Right of use Assets
Tenant improvements, Right of use Assets
Minimum liquidation preference [Line Items]
Minimum liquidation preference [Line Items]
Minimum liquidation preference
Disclosure of range of exercise prices of outstanding share options [table]
Disclosure of range of exercise prices of outstanding share options [table]
Disclosure of short-term and long-term portion of lease receivable
Disclosure of short-term and long-term portion of lease receivable [Text Block]
Disclosure of short-term and long-term portion of lease receivable
Non-cash items:
Non-cash items [Abstract]
Non-cash items
Equity Instruments Issued by the Group
Description of accounting policy for equity instruments issued by the group [Policy Text Block]
Description of accounting policy for equity instruments issued by the group
Purchase of convertible note
Purchases of Convertible Note
Purchases of Convertible Note
Series A-2 Preferred [Member]
Series A-2 Preferred [Member]
Series A-2 Preferred [Member]
Capital And Financial Risk Management Credit Risk [Abstract]
Capital And Financial Risk Management [Abstract]
Document and Entity Information [Line Items]
Document Information [Line Items]
No Trading Symbol Flag
No Trading Symbol Flag
Business Combination, Investment In Common Share, Initial Investment
Business Combination, Investment In Common Share, Initial Investment
Business Combination, Investment In Common Share, Initial Investment
Geographical areas [axis]
Geographical areas [axis]
Interest expense on lease liability
Interest expense
Interest expense on lease liabilities
Impairment of investment
Impairment loss (reversal of impairment loss) recognised in profit or loss
Classes of liabilities [axis]
Classes of liabilities [axis]
Customer B
Customer B [Member]
Customer B
Transferred over time
Goods or services transferred over time [member]
Aggregate payroll costs
Total Payroll Costs
Payroll Costs
Payroll Costs
Deferred tax liabilities, net, recognized
Net deferred tax liabilities
Borrowings by name [member]
Borrowings by name [member]
Disclosure of accumulated depreciation and impairment loss
Disclosure of accumulated depreciation and impairment loss [Text Block]
Disclosure of accumulated depreciation and impairment loss
Proceeds from sale of property and equipment
Proceeds from sales of property, plant and equipment, classified as investing activities
Sale of investments held at fair value
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities
Business combination, number of additional shares to be received at no additional cost
Business Combination, Number Of Additional Shares To Be Received At No Additional Cost
Business Combination, Number Of Additional Shares To Be Received At No Additional Cost
Disclosure of tax balances as presented in Statement of Financial Position
Disclosure of tax balances as presented in Statement of Financial Position [Text Block]
Disclosure of tax balances as presented in Statement of Financial Position
Issuance of long term loan
Proceeds from non-current borrowings
Segment Information [Abstract]
Segment Information [Abstract]
Entity Voluntary Filers
Entity Voluntary Filers
Accounting Policies - Subsidiaries [Table]
Accounting Policies - Subsidiaries [Table]
Accounting Policies - Subsidiaries
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Gain on investment at initial public offering
Gain on investment at initial public offering
Gain on investment at initial public offering
Settlement of RSU's
Settlement of RSU's
Settlement of RSU's
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets [abstract]
Total
Key management personnel compensation
Weighted average remaining contractual life of outstanding share options (in years)
Weighted average remaining contractual life of outstanding share options
Salaries and wages
Wages and salaries
Healthcare benefits
Employee benefits expense
Disclosure of Reconciliation of Effective Tax Rate
Disclosure of Reconciliation of Effective Tax Rate [Text Block]
Disclosure of Reconciliation of Effective Tax Rate
Financial Instruments - Warrants [Abstract]
Financial Instruments - Warrants [Abstract]
Financial Instruments - Warrants
Basis of consolidation
Disclosure of basis of consolidation [text block]
Later than ten years [member]
Later than ten years [member]
Interest paid
Borrowings, Interest paid
Borrowings, Interest paid
Potential securities excluded from diluted EPS calculation
Potential securities excluded from diluted EPS calculation
Potential securities excluded from diluted EPS calculation
Commense Inc.
Commense
Commense [Member]
Commense
Recognised Income Tax Expense [Line Items]
Recognised Income Tax Expense [Line Items]
Recognised Income Tax Expense
Total parent equity [member]
Equity attributable to owners of parent [member]
Subsidiary Operating Companies [Member]
Subsidiary Operating Companies [Member]
Subsidiary Operating Companies
Owners of the Company
Comprehensive income, attributable to owners of parent
Customer A
Customer A [Member]
Customer A
Subsidiary Convertible Notes
Subsidiary Convertible Notes [Member]
Subsidiary Convertible Notes
RSU [Line Items]
RSU [Line Items]
RSU
Entity Interactive Data Current
Entity Interactive Data Current
Net investment in the lease
Net investment in finance lease
Earnings Category [Domain]
Earnings Category [Domain]
Earnings Category [Domain]
Proportion of ownership interest in subsidiary
Proportion of ownership interest in subsidiary
Issuance of new preferred shares
Issue of equity
Contingent consideration recognised as of acquisition date
Contingent consideration recognised as of acquisition date
Fixed assets
Property, plant and equipment [member]
Dr Raju Kucherlapati
Dr Raju Kucherlapati [Member]
Dr Raju Kucherlapati
Other liabilities
Adjustments for increase (decrease) in other operating payables
Deconsolidation
Deconsolidation
Deconsolidation
Disclosure of Fair Value Measurement and Classification
Disclosure of fair value measurement [text block]
Disclosure of Property & Equipment, net
Schedule of Property & Equipment net [Text Block]
Schedule of Property & Equipment net
Cash and Cash Equivalents
Description of accounting policy for restricted cash and cash equivalents [text block]
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Effects of state tax rate in U.S.
Rate of Effects of state tax rate in US
Rate of Effects of state tax rate in US
Unrecognized deferred tax assets [Table]
Unrecognized deferred tax assets [Table]
Unrecognized deferred tax assets [Table]
Disclosure of Weighted-Average Number of Ordinary Shares
Weighted-Average Number of Ordinary Shares [Text Block]
Weighted-Average Number of Ordinary Shares
Segments [axis]
Segments [axis]
Entity Address, State or Province
Entity Address, State or Province
Subsequent Events [Abstract]
Subsequent Events [Abstract]
Deconsolidated former subsidiary operating companies
Deconsolidated former subsidiaries [Abstract]
Deconsolidated former subsidiaries
Income/(loss) before taxes
Income/(loss) before taxes
Profit (loss) before tax
Gain/(loss) on investments held at fair value
Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, assets
Financial Instruments
Description of accounting policy for financial instruments [text block]
Disclosure of Earnings/(Loss) attributable to owners of company
Earnings Loss attributable to owners of company [Text Block]
Earnings Loss attributable to owners of company
Current portion of long-term loan
Current portion of non-current borrowings
Income/(loss) from continuing operations (100%)
Profit (loss) from continuing operations
Group's share of net assets
Share of net assets
Share of net assets
Significant Subsidiary Plan -Vedanta 2010 Plan - Range of assumptions of Fair Value of stock option grants
Significant Subsidiary Plan -Vedanta 2010 Plan - Range of assumptions of Fair Value of stock option grants [Text Block]
Significant Subsidiary Plan - Vedanta - Range of assumptions of Fair Value of stock option grants
PureTech Health (Company)
PureTech Health (Company) [Member]
PureTech Health (Company)
Intangible assets, net
Balance at beginning of period
Balance at end of period
Intangible assets other than goodwill
Distributions
Increase (decrease) through other changes, equity
Finance costs – contractual
Total finance cost – contractual
Finance costs
Inactive subsidiaries
Inactive subsidiaries [Abstract]
Inactive subsidiaries
Trade and other receivables
Trade and other current receivables
Acquired minority non-controlling interest
Acquired minority non-controlling interest
Acquired minority non-controlling interest
Receipt of PPP loan
Proceeds from current borrowings
Four to five years
Later than four years and not later than five years [member]
Imbrium Therapeutics L.P. [Member]
Imbrium Therapeutics L.P. [Member]
Imbrium Therapeutics L.P.
Disclosure of financial liabilities [table]
Disclosure of financial liabilities [table]
Summary of Investments in Associates
Summary of Investments in Associates [Text Block]
Summary of Investments in Associates
Document Transition Report
Document Transition Report
Entity's total for impairment of financial assets [member]
Entity's total for impairment of financial assets [member]
Number of Options held
Number of Options held
Number of Options held
Subsidiary Preferred Shares [Abstract]
Subsidiary Preferred Shares [Abstract]
Subsidiary Preferred Shares [Abstract]
Share-based Payments Table [Line Items]
Share-based Payments Table [Line Items]
Share-based Payments Table
Risk free interest rate
Risk Free Interest Rate, measurement input [Member]
Risk Free Interest Rate, measurement input
Earnings/(Loss) per Share
Disclosure of earnings per share [text block]
Subsidiary Preferred Shares
Subsidiary Preferred Shares [Member]
Subsidiary Preferred Shares
Schedule of Convertible Notes
Schedule of Convertible Notes [Text Block]
Schedule of Convertible Notes
Conversion of subsidiary convertible note into subsidiary common stock (NCI)
Conversion of subsidiary Convertible note into subsidiary common stock
Conversion of subsidiary Convertible note into subsidiary common stock
Conversion of subsidiary convertible note into preferred share liabilities
Conversion of subsidiary Convertible note into preferred share liabilities
Conversion of subsidiary Convertible note into preferred share liabilities
Entity's total for associates [member]
Entity's total for associates [member]
ICFR Auditor Attestation Flag
ICFR Auditor Attestation Flag
Weighted average stock price of share options exercised in share-based payment arrangement (GBP)
Weighted average stock price of share options exercised in share-based payment arrangement
Weighted average stock price of share options exercised in share-based payment arrangement
Interest paid
Interest paid, classified as operating activities
Merger reserve [member]
Merger reserve [member]
Controlled Founded Entities
Controlled Founded Entities [Member]
Controlled Founded Entities
Weighted Average
Significant unobservable input, assets
Depreciation of tangible assets
Depreciation expense
Depreciation expense
Customers over 10% of revenue
Major customers [axis]
Major customers [axis]
Changes in the value of subsidiary preferred shares [Table]
Changes in the value of subsidiary preferred shares [Table]
Changes in the value of subsidiary preferred shares [Table]
Interest expense on other borrowings
Interest expense on borrowings
Document Shell Company Report
Document Shell Company Report
Discount Rate
Discount rate, measurement input [member]
Statement of changes in equity [abstract]
Other financial assets
Adjustments for decrease (increase) in other assets
Weighted Average Options forfeited [Line Items]
Weighted Average Options forfeited [Line Items]
Weighted Average Options forfeited
Total current assets
Current assets
Current assets
Lighthouse Capital Partners VI, L.P
Lighthouse Capital Partners VI, L.P [Member]
Lighthouse Capital Partners VI, L.P
Conversion of convertible notes into preferred shares - non cash financing activity
Conversion of convertible notes
Conversion of convertible notes
Subsidiary Preferred Shares
Disclosure of Subsidiary Preferred Shares [Text Block]
Disclosure of Subsidiary Preferred Shares
Revenue
Disclosure of revenue [text block]
Non-Controlling Interests [Abstract]
Non-Controlling Interests [Abstract]
Non-Controlling Interests [Abstract]
Intangible Assets
Disclosure of detailed information about intangible assets [line items]
Disclosure of operating segments
Disclosure of operating segments [text block]
Share-based Payment Arrangement after tax deduction, Cash Used to Settle Award
Share-based Payment Settlement, cash received by employee after tax withheld on employee's behalf
Share-based Payment Settlement, cash received by employee after tax withheld on employee's behalf
Additions
Additions to right-of-use assets
Dr Robert Langer [Member]
Dr Robert Langer [Member]
Dr Robert Langer
Disclosure of other operating expense
Disclosure of other operating expense [text block]
Subsidiary Preferred Shares [Table]
Subsidiary Preferred Shares [Table]
Subsidiary Preferred Shares [Table]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [text block]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [text block]
Equity - Acquired Share capital PureTech LLC [Table]
Equity - Acquired Share capital PureTech LLC [Table]
Equity - Acquired Share capital PureTech LLC [Table]
Proceeds from issuance of convertible notes in subsidiary
Proceeds from issue of bonds, notes and debentures
Liability for share based awards
Liabilities from share-based payment transactions
Weighted Average Options Outstanding [Abstract]
Weighted Average Options Outstanding [Abstract]
Weighted Average Options Outstanding
Grant date fair value
Weighted average fair value at measurement date, share options granted
Other selling, general and administrative expenses
Other Selling General and Administrative Expense
Other Selling General and Administrative Expense
Investor [Member]
Investor [Member]
Investor
Depreciation and amortization
Adjustments for depreciation and amortisation expense
Performance Share Plan [Abstract]
Performance Share Plan [Abstract]
Performance Share Plan
Business Combination, Investment In Common Share
Business Combination, Investment In Common Share
Business Combination, Investment In Common Share
Other temporary differences
Other temporary differences [member]
Disclosure of range of exercise prices of outstanding share options [line items]
Disclosure of range of exercise prices of outstanding share options [line items]
Diluted earnings (loss) per share
Diluted earnings (loss) per share
Unearned Finance income
Unearned finance income relating to finance lease payments receivable
Finance Income and Finance Costs
Description of accounting policy for finance income and costs [text block]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [line items]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [line items]
Total deferred income tax expense/(benefit)
Deferred tax expense (income)
Granted (in shares)
Number of other equity instruments granted in share-based payment arrangement
Document Fiscal Year Focus
Document Fiscal Year Focus
Share-based payment expense
Share-based payments
Expense from share-based payment transactions with employees
Tax Losses
Tax losses expiring
Unused tax losses for which no deferred tax asset recognised
Financial Instruments [Abstract]
Financial Instruments [Abstract]
Financial Instruments [Abstract]
Operating Loss Carryforwards Not Subject To Expiration
Operating Loss Carryforwards Not Subject To Expiration [Member]
Operating Loss Carryforwards Not Subject To Expiration
Reconciliation of changes in fair value measurement, assets [abstract]
Reconciliation of changes in fair value measurement, assets [abstract]
Akili and Gelesis [Member]
Akili and Gelesis [Member]
Akili and Gelesis
Weighted Average number of ordinary shares [Table]
Weighted Average number of ordinary shares [Table]
Weighted Average number of ordinary shares
ROU asset
Right-of-use assets [member]
Long-term loan
Non-current portion of non-current borrowings
Class B Common [Member]
Class B Common [Member]
Class B Common
Share-based Payment Expense Category [Axis]
Share-based Payment Expense Category [Axis]
Share-based Payment Expense Category
Investments in associates
As of period start
As of period end
Investments in associates reported in separate financial statements
Distribution to Tal shareholders
Distribution to Tal Shareholders
Distribution to Tal Shareholders
Other Financial Assets
Disclosure of other assets [text block]
Revenue recognized on deferred revenue outstanding at prior year end
Revenue recognized on deferred revenue outstanding at prior year end
Revenue recognized on deferred revenue outstanding at prior year end
New Standards and Interpretations Not Yet Adopted [Abstract]
New Standards and Interpretations Not Yet Adopted [Abstract]
Deferred revenues
Adjustments for increase decrease In deferred revenue
Adjustments for increase decrease In deferred revenue
Outside investors
Outside investors [Member]
Outside investors
Impairment
Description of accounting policy for impairment of non-financial assets [text block]
Information about credit quality of neither past due nor impaired financial assets
Information about credit quality of neither past due nor impaired financial assets [text block]
Maximum
Maximum [Member]
resTORbio [Member]
resTORbio [Member]
resTORbio
Address Type [Domain]
Address Type [Domain]
Gain on deconsolidation
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
Share of net income/(loss) of associates accounted for using the equity method
Share of associate loss allocated to long-term interest (please refer to Note 5)
Share of profit (loss) of associates and joint ventures accounted for using equity method
Associate common stock held at fair value
Associate common stock held at fair value
Associate common stock held at fair value
Cash paid for income taxes
Income taxes paid (refund)
Intra-group eliminations
Intra-group eliminations [Member]
Intra-group eliminations
Expense in respect of RSU liability award
Expense in respect of RSU liability award
Expense in respect of RSU liability award
Weighted Average [Table]
Weighted Average Options granted [Table]
Weighted Average [Table]
Revaluation of deferred tax assets related to share-based awards
Decrease (increase) through tax on share-based payment transactions, equity
Exercise price of the warrants
Exercise price, measurement input [Member]
Exercise price, measurement input
Property, plant and equipment [abstract]
Deductible Temporary Difference
Deductible temporary differences for which no deferred tax asset is recognised
City Area Code
City Area Code
Time to Liquidity
Time to Liquidity, measurement input [Member]
Time to Liquidity, measurement input
Over 10 percent of revenue
Over 10 percent of revenue [Member]
Over 10 percent of revenue
Cash purchase of preferred shares
Purchase of interests in associates
Royalty income
Royalty income
Purchase of associate preferred shares held at fair value
Purchase of investments other than investments accounted for using equity method
Purchase of investments other than investments accounted for using equity method
Weighted average grant date fair value, RSU outstanding beginning balance (in GBP per share)
Weighted average grant date fair value, RSU Ending balance (in GBP per share)
Weighted average grant date fair value of other equity instruments outstanding in share-based payment arrangement
Weighted average grant date fair value of other equity instruments outstanding in share-based payment arrangement
Performance Share Plan [Table]
Performance Share Plan [Table]
Performance Share Plan [Table]
Disclosure Of changes in Financial Liabilities, level 3 fair value - Subsidiary Preferred Shares and Convertible Notes
Disclosure Of changes in Financial Liabilities, level 3 fair value - Subsidiary Preferred Shares and Convertible Notes [Text Block]
Disclosure Of changes in Financial Liabilities, level 3 fair value - Subsidiary Preferred Shares and Convertible Notes
Equity attributable to the owners of the Company
Equity attributable to owners of the Group
Equity attributable to owners of parent
Disclosure of Accumulated amortization
Disclosure of Accumulated amortization [Text Block]
Disclosure of Accumulated amortization
Supplemental disclosure of non-cash investment and financing activities:
Supplemental disclosure of non-cash investment and financing activities [Abstract]
Supplemental disclosure of non-cash investment and financing activities
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [abstract]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [abstract]
Disclosure of Equity
Summary of Equity [Text Block]
Summary of Equity
Weighted average exercise price of, options exercisable (GBP)
Weighted-average exercise price $
Weighted average exercise price of share options exercisable in share-based payment arrangement
Shareholder ownership percentage
Weighted average shareholder ownership percentage in associate
Weighted average shareholder ownership percentage in associate
Operating Loss Carryforwards, Expiration Periods [Domain]
Operating Loss Carryforwards, Expiration Periods [Domain]
Operating Loss Carryforwards, Expiration Periods
Disclosure of maturity analysis of finance lease payments receivable [table]
Disclosure of maturity analysis of finance lease payments receivable [table]
Ensof Biosystems, Inc. (held indirectly through Enlight)
Ensof Biosystems Inc [Member]
Ensof Biosystems Inc
Disclosure of Intangible assets, net
Schedule of Intangible assets net [Text Block]
Schedule of Intangible assets net
Liabilities
Liabilities [abstract]
Disclosure of financial assets [abstract]
Adjustments to reconcile net operating loss to net cash used in operating activities:
Adjustments to reconcile profit (loss) [abstract]
Classes of financial instruments [axis]
Classes of financial instruments [axis]
CapStar Special Purpose Acquisition Corp
CapStar Special Purpose Acquisition Corp [Member]
CapStar Special Purpose Acquisition Corp
Financial Assets
Description of accounting policy for financial assets [text block]
Significant Subsidiary Plans [Table]
Significant Subsidiary Plans [Table]
Significant Subsidiary Plans [Table]
Series B Preferred [Member]
Series B Preferred [Member]
Series B Preferred
Impairment of investment in associate
Impairment of investment in associate
Impairment of investment in associate
Disclosure of Changes in the value of subsidiary preferred shares
Changes in the value of subsidiary preferred shares [Text Block]
Changes in the value of subsidiary preferred shares
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [abstract]
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [abstract]
Entity Registrant Name
Entity Registrant Name
Purchase of investments held at fair value
Cash purchase of preferred shares
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
Dr Bharatt Chowrira
Dr Bharatt Chowrira [Member]
Dr Bharatt Chowrira
Rental income
Rental income
Expected term
Expected term, measurement input [Member]
Expected term, measurement input
Functional and Presentation Currency
Description of accounting policy for functional currency [text block]
Weighted Average Options granted [Line Items]
Weighted Average Options granted [Line Items]
Weighted Average Options granted
Income/(loss) before taxes pre IFRS 9 fair value accounting, finance costs – subsidiary preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets
Profit Loss Before Tax pre IFRS 9 fair value accounting, finance costs – subsidiary preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets
Profit Loss Before Tax pre IFRS 9 fair value accounting, finance costs – subsidiary preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets
Weighted Average Options granted [Abstract]
Weighted Average Options granted [Abstract]
Weighted Average Options granted
1.00 to 2.00
Exercise Price Range Two [Member]
Exercise Price Range Two [Member]
Timing of transfer of goods or services [member]
Timing of transfer of goods or services [member]
Subsidiaries
Description of accounting policy for subsidiaries [text block]
Related party transactions [Table]
Related party transactions [Table]
Related party transactions
Share-based payments
Share-based payments [Member]
Share-based payments
Current Liabilities From Share based Payment Transactions
Current Liabilities From Share based Payment Transactions
Current Liabilities From Share based Payment Transactions
Document Fiscal Period Focus
Document Fiscal Period Focus
Financial Instruments - Warrants [Table]
Financial Instruments - Warrants [Table]
Financial Instruments - Warrants [Table]
Share-based Payment Expense [Abstract]
Share-based Payments [Abstract]
Share-based Payments [Abstract]
Foreign [Member]
Foreign [Member]
Foreign
Deferred tax assets (liabilities), net
Deferred tax liability (asset)
Financial Instruments, Significant Unobservable inputs, level 3 fair value - Preferred Shares liability
Financial Instruments, Significant Unobservable inputs, level 3 fair value - Preferred Shares liability [Text Block]
Financial Instruments, Significant Unobservable inputs, level 3 fair value - Preferred Shares liability
Borrowings, interest rate
Borrowings, interest rate
Depreciation
Depreciation, property, plant and equipment
Disclosure of significant unobservable inputs used in fair value measurement of assets [table]
Disclosure of significant unobservable inputs used in fair value measurement of assets [table]
Appeering Inc.
Appeering
Appeering [Member]
Appeering
Nontrading Holding Companies [Member]
Nontrading Holding Companies [Member]
Nontrading Holding Companies
Operating segments [member]
Operating segments [member]
Short-term employee benefits
Key management personnel compensation, short-term employee benefits
Share premium [member]
Share premium [member]
Accounts receivable
Receivables from contracts with customers
Auditor Information [Abstract]
Auditor Information
Consolidated Statements of Comprehensive Income/(Loss)
Statement of comprehensive income [abstract]
PureTech LYT (formerly Ariya Therapeutics, Inc.)
PureTech LYT [Member]
PureTech LYT [Member]
PureTech LYT
American Depositary Shares
American Depositary Shares [Member]
American Depositary Shares
Deferred Tax Assets and Liabilities [Line Items]
Deferred Tax Assets and Liabilities [Line Items]
Deferred Tax Assets and Liabilities
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities, warrants
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities, warrants [Text Block]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities, warrants
Inactive Subsidiaries [Member]
Inactive Subsidiaries [Member]
Inactive Subsidiaries
Exercised (in shares)
Exercised During the Year
Number of share options exercised in share-based payment arrangement
Expired During the Year
Number of share options expired in share-based payment arrangement
Earnings Loss per Share [Line Items]
Earnings Loss per Share [Line Items]
Earnings Loss per Share
Disclosure of auditors' remuneration
Disclosure of auditors' remuneration [text block]
Enlight Biosciences, LLC
Enlight [Member]
Enlight [Member]
Enlight
Sale of shares
Sales, fair value measurement, assets
Disclosure of operating segments [table]
Disclosure of operating segments [table]
Convertible Notes [Line Items]
Convertible Notes [Line Items]
Convertible Notes
Disclosure of Weighted Average Exercise Prices for Options Outstanding
Disclosure of Weighted Average Exercise Prices for Options Outstanding [Text Block]
Disclosure of Weighted Average Exercise Prices for Options Outstanding
Counterparty Name [Domain]
Counterparty Name [Domain]
Furniture and fixtures
Fixtures and fittings [member]
Document Registration Statement
Document Registration Statement
Basic [Member]
Basic [Member]
Basic
Discount, conversion from notes - non qualified financing
Discount, conversion from notes - non qualified financing
Discount, conversion from notes - non qualified financing
Financial assets, class [member]
Financial assets, class [member]
Undiscounted operating lease payments to be received
Undiscounted operating lease payments to be received
Increase and Decrease Through Change In NCI Share In Subsidiary Deficit
Increase and Decrease Through Change In NCI Share In Subsidiary Deficit
Increase and Decrease Through Change In NCI Share In Subsidiary Deficit
Classes of financial liabilities [axis]
Classes of financial liabilities [axis]
Investment in Associates
Investments in associates [Member]
Investments in associates
Disclosure of revenue from contracts with customers
Disclosure of revenue from contracts with customers [text block]
Auditor Location
Auditor Location
Financial Liability Increase/ (Decrease)
Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, liabilities
Accounts receivable
Adjustments for decrease (increase) in trade and other receivables
Subsidiary Notes Payable - Loans [Line Items]
Subsidiary Notes Payable - Loans [Line Items]
Subsidiary Notes Payable - Loans
Acquisition of equity instruments in other entities
Acquisition of equity instruments in other entities
Acquisition of equity instruments in other entities
Related parties [member]
Related parties [member]
Sensitivity analysis for equity price risk, impact on pre-tax earnings
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Pre-Tax Earnings
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Pre-Tax Earnings
Disclosure of disaggregation of revenue from contracts with customers [line items]
Disclosure of disaggregation of revenue from contracts with customers [line items]
Deconsolidated former Subsidiary Operating Companies [Member]
Deconsolidated former Subsidiary Operating Companies [Member]
Deconsolidated former Subsidiary Operating Companies
Weighted Average Options forfeited [Table]
Weighted Average Options forfeited [Table]
Weighted Average Options forfeited [Table]
Revenue [Line Items]
Revenue [Line Items]
Revenue
Disclosure of information of employees [Line Items]
Disclosure of information of employees [Line Items]
Disclosure of information of employees [Line Items]
Libra Biosciences, Inc.
Libra Biosciences Inc [Member]
Libra Biosciences Inc
Disclosure of unrecognized deferred tax assets [text block]
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]
Impairment of investment in associate
Adjustment of Impairment of investment in associate
Adjustment of Impairment of investment in associate
Total equity
Equity at beginning of period
Equity at end of period
Equity
Operating Expenses Table [Table]
Operating Expenses Table [Table]
Operating Expenses Table
Title of 12(b) Security
Title of 12(b) Security
Disclosure of disaggregation of revenue from contracts with customers [table]
Disclosure of disaggregation of revenue from contracts with customers [table]
PureTech Securities Corp.
PureTech Securities Corp. [Member]
PureTech Securities Corp.
Investment, Name [Domain]
Investment, Name [Domain]
Series C Preferred [Member]
Series C Preferred [Member]
Series C Preferred
Financial Liability Increase/ (Decrease)
Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, liabilities
Document Type
Document Type
Fair value input, common stock price
Fair Value Input, Common Stock Price
Fair Value Input, Common Stock Price
Aggregated measurement [member]
Aggregated measurement [member]
Business Contact
Business Contact [Member]
Equity price risk [member]
Equity price risk [member]
Customer E
Customer E [Member]
Customer E
Other
Other inflows (outflows) of cash, classified as financing activities
Disclosure of Income Taxes Recognized in Comprehensive Income
Disclosure of Income Taxes Recognized in Comprehensive Income [Text Block]
Disclosure of Income Taxes Recognized in Comprehensive Income
Sensitivity analysis for equity price risk, impact on pre-tax earnings, percentage
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Percentage
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Percentage
Grant Income
Description of accounting policy for government grants [text block]
Prepaid expenses and other current assets
Adjustments for decrease (increase) in other current assets
Dr John LaMattina and Ms Mary LaMattina
Dr John LaMattina and Ms Mary LaMattina [Member]
Dr John LaMattina and Ms Mary LaMattina
Types of risks [axis]
Types of risks [axis]
Leasehold improvements purchased through lease incentives (deducted from Right of Use Asset)
Leasehold improvements purchased through lease incentives
Leasehold improvements purchased through lease incentives
Share-based Payments Table [Table]
Share-based Payments Table [Table]
Share-based Payments Table [Table]
Purchase of non controlling interest in consideration for issuance of shares and options
Purchase of non controlling interest in consideration for issuance of shares and options
Purchase of non controlling interest in consideration for issuance of shares and options
Issuance of shares to NCI in subsidiary
Proceeds From Issue Of shares to NCI
Proceeds From Issue Of shares to NCI
Disclosure of terms and conditions of share-based payment arrangement [line items]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Preferred D shares
Preferred D shares [Member]
Preferred D shares
Customer C
Customer C [Member]
Customer C
Reconciliation of average effective tax rate and applicable tax rate [abstract]
Other research and development expenses
Other Research And Development Expense
Other Research And Development Expense
Unrecognized deferred tax assets [Line Items]
Unrecognized deferred tax assets [Line Items]
Unrecognized deferred tax assets [Line Items]
Conversion to preferred
Conversion to preferred
Conversion to preferred
Unrealized gain – fair value through profit and loss
Increase (decrease) in fair value measurement, assets
Deferred tax assets (liabilities), net, not recognized
Total
Net deferred tax assets, not recognised
Net deferred tax assets, not recognised
Non deductible share based payment expenses
Rate of Share based Payment expenses, non-deductible, reconciliation of effective tax rate
Rate of Share based Payment expenses, non-deductible
Reclassifications
Increase (decrease) through transfers from construction in progress, property, plant and equipment
Non-current assets
Non-current assets [abstract]
Payroll Taxes
Payroll Taxes
Payroll Taxes
Unrecognised Share Of Losses Of Associates, Other Comprehensive Loss
Unrecognised Share Of Losses Of Associates, Other Comprehensive Loss
Unrecognised Share Of Losses Of Associates, Other Comprehensive Loss
Fair value gain on derivative
Adjustments for gains (losses) on change in fair value of derivatives
Equity and liabilities
Equity and liabilities [abstract]
Subsidiary Notes Payable [Abstract]
Subsidiary Notes Payable [Abstract]
Subsidiary Notes Payable [Abstract]
Geographical areas [member]
Geographical areas [member]
Acquisition of subsidiary non-controlling interest
Increase (decrease) through acquisition of subsidiary, equity
Schedule of Notes Payable
Schedule of Notes Payable [Text Block]
Schedule of Notes Payable
Disclosure of operating segments [line items]
Disclosure of operating segments [line items]
Key Management Personnel Compensation
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block]
Basis of Presentation
Disclosure of basis of preparation of financial statements [text block]
Owners of the Company
Income/(loss) for the year, attributable to the owners of the Company
Profit (loss), attributable to owners of parent
Weighted average remaining contractual life of options excisable (in years)
Weighted average remaining contractual life of options excisable
Weighted average remaining contractual life of options excisable
Proceeds from the issuance of shares and subsidiary preferred shares
Proceeds from issuing shares
Cash flows from operating activities
Cash flows from (used in) operating activities [abstract]
Liquidity Risk [Line Items]
Liquidity Risk [Line Items]
Liquidity Risk
Classes of property, plant and equipment [axis]
Classes of property, plant and equipment [axis]
Levels of fair value hierarchy [axis]
Levels of fair value hierarchy [axis]
Gain/(loss) on foreign currency exchange
Gain Loss on foreign currency exchange in finance costs
Gain Loss on foreign currency exchange in finance costs
Vor Biopharma Inc.
Vor [Member]
Vor [Member]
Vor
Disclosure of maturity analysis of finance lease payments receivable
Disclosure of maturity analysis of finance lease payments receivable [text block]
Not impaired
Not impaired [Member]
Not impaired
Investments held at fair value
Beginning balance
Ending balance after allocation of share in associate loss to long-term interest1
Non-current financial assets at fair value through profit or loss
Sensitivity Range
Percentage of reasonably possible increase in unobservable input, assets
Trade and other receivables
Current trade receivables
2024
Two to three years
Later than two years and not later than three years [member]
Balance before allocation of share in associate loss to long-term interest
Financial Assets At Fair Value Through Profit Or Loss before allocation to long-term interest
Financial Assets At Fair Value Through Profit Or Loss before allocation to long-term interest
IFRS 15, Revenue from Contracts with Customers
Description of accounting policy for recognition of revenue [text block]
Balance at beginning of period
Balance at end of period
Total lease liabilities
Lease liabilities
Assets [member]
Assets [member]
Non-controlling interests [member]
Non-controlling interests [member]
Disclosure of financial assets [table]
Disclosure of financial assets [table]
Share-based Payments
Description of accounting policy for share-based payment transactions [text block]
Other
Other tax effects for reconciliation between accounting profit and tax expense (income)
Gross Amount
Gross Amount [Member]
Gross Amount
Net cash used in operating activities
Cash flows from (used in) operating activities
Other reserves [member]
Other reserves [member]
US federal statutory rate
Applicable tax rate
Non-Controlling Interests [Table]
Non-Controlling Interests [Table]
Non-Controlling Interests
Long-term loan
Disclosure of borrowings [text block]
Long-term loan [Abstract]
Long-term loan [Abstract]
Document Period End Date
Document Period End Date
Translation reserve
Reserve of exchange differences on translation
Conversion of note receivable
Conversion of note receivable
Conversion of note receivable
Statement of changes in equity [table]
Statement of changes in equity [table]
Deferred revenue
Deferred revenue – short term
Current contract liabilities
Minimum liquidation preference [Abstract]
Minimum liquidation preference [Abstract]
Minimum liquidation preference
Recognised Income Tax Expense [Table]
Recognised Income Tax Expense [Table]
Recognised Income Tax Expense [Table]
Disclosure of detailed information about intangible assets [table]
Disclosure of detailed information about intangible assets [table]
Reconciliation of Effective Tax Rate [Table]
Reconciliation of Effective Tax Rate [Table]
Reconciliation of Effective Tax Rate [Table]
Sensitivity Range
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Decrease In Risk Variable, Period
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Decrease In Risk Variable, Period
Contractual interest expense on notes payable
Contractual Interest expense on notes
Contractual Interest expense on notes
Proportion of ownership interest in subsidiary, additional ownership acquired
Proportion of ownership interest in subsidiary, additional ownership acquired
Proportion of ownership interest in subsidiary, additional ownership acquired
Convertible Notes [Member]
Convertible Notes [Member]
Convertible Notes
Credit Risk Abstract [Abstract]
Liquidity Risk [Abstract]
Liquidity Risk
Trade and other payables
Total trade and other payables
Trade and other current payables
Convertible instruments, interest rate
Convertible instruments, interest rate
Convertible instruments, interest rate
Cost
Principal
Gross carrying amount [member]
Subsequent Events
Disclosure of events after reporting period [text block]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets [text block]
Weighted Average Options outstanding [Table]
Weighted Average Options outstanding [Table]
Weighted Average Options outstanding [Table]
Financial Instruments - Warrants [Roll Forward]
Financial Instruments - Warrants [Roll Forward]
Financial Instruments - Warrants
Series 3 Growth Preferred Stock
Series 3 Growth Preferred Stock [Member]
Series 3 Growth Preferred Stock
Investments held at fair value [Table]
Investments held at fair value [Table]
Investments held at fair value
Financial Instruments - Warrants [Line Items]
Financial Instruments - Warrants [Line Items]
Financial Instruments - Warrants
Unobservable inputs [axis]
Unobservable inputs [axis]
Trade and other receivables [member]
Trade receivables [member]
Probability of success, measurement input
Probability of success, measurement input [Member]
Probability of success, measurement input
R&D and orphan drug tax credits
Research And Development and orphan drug tax credits, reconciliation of effective tax rate
Research And Development and orphan drug tax credits, reconciliation of effective tax rate
Subsidiary Plans [Table]
Subsidiary Plans [Table]
Subsidiary Plans [Table]
Summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations [Table]
Summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations [Table]
Summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations
Earnings/(loss) per share:
Earnings per share [abstract]
Other current financial liabilities
Other current financial liabilities
Gain on deconsolidation [Abstract]
Gain on deconsolidation [Abstract]
Gain on deconsolidation
Total equity and liabilities
Equity and liabilities
Total revenue
Revenue
Total revenue
Revenue
Weighted Average Options forfeited [Abstract]
Weighted Average Options forfeited [Abstract]
Weighted Average Options forfeited
(Loss)/income before taxes pre IAS 39 fair value accounting, finance costs – subsidiary preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets
Profit Loss Before Tax pre IAS 39
Profit Loss Before Tax pre IAS 39
Income/(loss) attributable to ordinary shareholders
Profit Loss Attributable To Ordinary Shareholders
Profit Loss Attributable To Ordinary Shareholders
Operating Expenses
Disclosure Of Operating Expense Explanatory [Text Block]
Disclosure Of Operating Expense Explanatory
2.00 to 3.00
Exercise Price Range Three [Member]
Exercise Price Range Three [Member]
Accounting Policies
Accounting Policies [Line Items]
Accounting Policies
Leases [Abstract]
Leases [Abstract]
Leases [Abstract]
Finance lease payments receivable [Line Items]
Finance lease payments receivable [Line Items]
Finance lease payments receivable
PureTech and third-party
PureTech and third-party [Member]
PureTech and third-party
Entity Current Reporting Status
Entity Current Reporting Status
Disclosure of short-term and long-term portion of lease liability
Disclosure of short-term and long-term portion of lease liability [Text Block]
Disclosure of short-term and long-term portion of lease liability
Non-Controlling Interests [Line Items]
Non-Controlling Interests [Line Items]
Non-Controlling Interests
Schedule of Contract Balances
Schedule of Contract Balances [Text Block]
Schedule of Contract Balances
Minimum liquidation preference [Table]
Minimum liquidation preference [Table]
Minimum liquidation preference [Table]
Gain/(Loss) from change in fair value of warrant liability
Gain/(Loss) from change in fair value of warrant liability
Gain/(Loss) from change in fair value of warrant liability
Adjustments
Adjustments, right-of-use assets
Adjustments, right-of-use assets
Accrued expenses
Accruals classified as current
Document Accounting Standard
Document Accounting Standard
Total
Credit exposure
Top of range [member]
Top of range [member]
PureTech Management, Inc.
PureTech Management [Member]
PureTech Management
Net cash provided by investing activities
Cash flows from (used in) investing activities
2017 Performance Based RSU [Member]
2017 Performance Based RSU [Member]
2017 Performance Based RSU
New Standards and Interpretations Not Yet Adopted
Disclosure of expected impact of initial application of new standards or interpretations [text block]
Weighted average [member]
Weighted average [member]
Counterparty Name [Axis]
Counterparty Name [Axis]
Taxation [Table]
Taxation [Table]
Taxation
UNITED STATES
UNITED STATES
Audit of the financial statements of subsidiaries
Audit of financial statements of subsidiaries
Audit of financial statements of subsidiaries
Disclosure of finance income (cost) [text block]
Disclosure of finance income (cost) [text block]
Borrowings by name [axis]
Borrowings by name [axis]
Income taxes paid
Income taxes paid (refund), classified as operating activities
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Property and Equipment
Disclosure of property, plant and equipment [text block]
Earnings/(Loss) attributable to owners of the Company [Abstract]
Earnings/(Loss) attributable to owners of the Company [Abstract]
Earnings/(Loss) attributable to owners of the Company
Disclosure of significant unobservable inputs used in fair value measurement of assets [abstract]
Disclosure of significant unobservable inputs used in fair value measurement of assets [abstract]
Weighted average grant date fair value, RSU forfeited (in GBP per share)
Weighted average grant date fair value of other equity instruments forfeited in share-based payment arrangement
Weighted average grant date fair value of other equity instruments forfeited in share-based payment arrangement
Number of share options granted in share-based payment arrangement
Granted (in shares)
Number of share options granted in share-based payment arrangement
Mandara Sciences, LLC
Mandara Sciences LLC [Member]
Mandara Sciences LLC
Total liabilities
Total Liabilities
Liabilities
2023
One to two years
Later than one year and not later than two years [member]
Net increase in cash and cash equivalents
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
Share-based Payment Arrangements, Authorized Amount, Percentage of Common Shares Outstanding
Share-based Payment Arrangements, Authorized Amount, Percentage of Common Shares Outstanding
Share-based Payment Arrangements, Authorized Amount, Percentage of Common Shares Outstanding
Proportion of voting rights held in associate
Proportion of voting rights held in associate
Gain/(Loss) from change in fair value of preferred shares
Gain/(Loss) from change in fair value of preferred shares
Gain/(Loss) from change in fair value of preferred shares
Operating Expense Category [Axis]
Operating Expense Category [Axis]
Operating Expense Category
Increase in value of preferred shares measured at fair value
Change in fair value
Change in fair value
Change in fair value
Taxation
Disclosure of income tax [text block]
Accounting Policies [Table]
Accounting Policies [Table]
Accounting Policies [Table]
Entity Address, Address Line One
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Two
Other income/(expense)
Other income/(expense)
Other gains (losses)
Intangible Assets [Abstract]
Intangible Assets [Abstract]
Intangible Assets
Weighted average ordinary shares and adjusted weighted average ordinary shares [abstract]
Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]
Entity Shell Company
Entity Shell Company
Disclosure of range of exercise prices of outstanding share options
Disclosure of range of exercise prices of outstanding share options [text block]
Short-term note [Abstract]
Short-term note [Abstract]
Short-term note
Weighted Average Options exercised [Abstract]
Weighted Average Options exercised
Grant revenue
Income from government grants
Deconsolidation of subsidiary
Increase (decrease) through disposal of subsidiary, equity
Deferred tax assets, net, recognized
Net deferred tax assets
Disclosure of recognized income tax expense
Disclosure of recognized income tax expense [Text Block]
Disclosure of recognized income tax expense
Financial Instruments - Fair value Measurement and Classification [Line Items]
Financial Instruments - Fair value Measurement and Classification [Line Items]
Financial Instruments - Fair value Measurement and Classification
Net finance income/(costs)
Finance income/(costs), net
Finance Costs
Finance income (cost)
Number of shares issued and fully paid
Number of shares issued and fully paid
Short-term and Long-term portion of lease liability [Table]
Short-term and Long-term portion of lease liability [Table]
Short-term and Long-term portion of lease liability
Disclosure of detailed information about intangible assets
Disclosure of detailed information about intangible assets [text block]
Convertible Notes [Table]
Convertible Notes [Table]
Convertible Notes [Table]
Current Fiscal Year End Date
Current Fiscal Year End Date
Finance costs [Abstract]
Finance costs [Abstract]
Finance costs
Liabilities, intercompany eliminations between parent company and reportable segments
Liabilities, intercompany eliminations between parent company and reportable segments
Liabilities, intercompany eliminations between parent company and reportable segments
Tax credits
Unused tax credits [member]
Share premium
Share premium
Total non-current assets
Non-current assets
Non-current assets
Forfeited (in shares)
Forfeited During the Year
Number of share options forfeited in share-based payment arrangement
Weighted average exercise price, options forfeited (GBP)
Weighted-average exercise price $
Weighted average exercise price of share options forfeited in share-based payment arrangement
Subsidiary Types [Domain]
Subsidiary Types [Domain]
Subsidiary Types [Domain]
Profit or loss [abstract]
Measurement Input, Probability Of Occurrence
Measurement Input, Probability Of Occurrence [Member]
Measurement Input, Probability Of Occurrence
Bottom of range [member]
Bottom of range [member]
Effect of dilutive shares
Dilutive effect of share options on number of ordinary shares
Types of customers [axis]
Types of customers [axis]
Disclosure of Long-term loan obligations
Disclosure of long-term loan obligations [Text Block]
Disclosure of long-term loan obligations
Current financial liabilities
Beginning balance
Ending balance
Current financial liabilities
Business combination, additional shares to be received at no additional cost, fair value
Business Combination, Additional Shares To Be Received At No Additional Cost, Fair Value
Business Combination, Additional Shares To Be Received At No Additional Cost, Fair Value
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Consideration for acquired non-controlling interest, first installment
Consideration for acquired non-controlling interest, first installment
Consideration for acquired non-controlling interest, first installment
Disclosure of unrecognized tax losses and tax credits carryforwards
Disclosure of unrecognized tax losses and tax credits, deferred tax assets [Text Block]
Disclosure of unrecognized tax losses and tax credits, deferred tax assets
Disclosure of changes in assets, level 3 fair value - investments held at fair value [Text Block]
Disclosure of changes in assets, level 3 fair value - investments held at fair value [Text Block]
Disclosure of changes in assets, level 3 fair value - investments held at fair value
Additions
Additions other than through business combinations, intangible assets other than goodwill
Investments held at fair value [Line Items]
Investments held at fair value [Line Items]
Investments held at fair value
Performance obligations satisfied over time [member]
Performance obligations satisfied over time [member]
Financial liabilities, class [member]
Financial liabilities, class [member]
Investments held at fair value
Investments held at fair value [Member]
Investments held at fair value
Deferred tax liability
Deferred tax liabilities
Deferred tax liabilities
Earnings Loss per Share [Table]
Earnings Loss per Share [Table]
Earnings Loss per Share [Table]
Debt instrument, payment terms, final fee trigger amount
Debt instrument, payment terms, final fee trigger amount
Debt instrument, payment terms, final fee trigger amount
Share-based Payments
Disclosure of share-based payment arrangements [text block]
Voting percentage through the holdings
Proportion of voting rights held in subsidiary
Acquisition cost
Acquisition cost
Acquisition cost
Foreign currency translation differences
Gains (losses) on exchange differences on translation of foreign operations, before tax
Percent voting rights of the Companny
Percent voting rights of the Company
Percent voting rights of the Company
Subsidiary Preferred Shares [Line Items]
Subsidiary Preferred Shares [Line Items]
Subsidiary Preferred Shares
Gain on deconsolidation [Line Items]
Gain on deconsolidation [Line Items]
Gain on deconsolidation
Effects of state tax rate in US
Effects of state tax rate in US, reconciliation of effective tax rate
Effects of state tax rate in US, reconciliation of effective tax rate
Equity [member]
Equity [member]
Taxation [Line Items]
Taxation [Line Items]
Taxation
Finance income/(costs) – fair value accounting
Finance income/(costs) – IFRS 9 fair value accounting
Total Finance income/(costs) - fair value accounting
Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, liabilities
Range [axis]
Range [axis]
Liabilities [member]
Liabilities [member]
RSU [Abstract]
RSU
Property, plant and equipment [Table]
Disclosure of detailed information about property, plant and equipment [table]
Subsidiaries [axis]
Subsidiaries [axis]
Performance, market and service based RSU
Performance, market and service based RSU [Member]
Performance, market and service based RSU
Disclosure of deferred taxes
Disclosure of deferred taxes [text block]
Purchase of short-term note from associate
Payment To Acquire Short-term Notes Receivable From Associate
Payment To Acquire Short-term Notes Receivable From Associate
Assets
Assets [abstract]
Statistical Measurement [Domain]
Statistical Measurement [Domain]
Net assets attributable to shareholders
Net assets attributable to shareholders of associate
Net assets attributable to shareholders of associate
Entity Addresses, Address Type [Axis]
Entity Addresses, Address Type [Axis]
Disclosure of RSU activity
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
Directors and Senior Managers Shareholdings and Share Incentive awards [Table]
Directors and Senior Managers Shareholdings and Share Incentive awards [Table]
Directors and Senior Managers Shareholdings and Share Incentive awards
PureTech Securities II Corp.
PureTech Securities II Corp. [Member]
PureTech Securities II Corp.
2025
Three to four years
Later than three years and not later than four years [member]
At fair value [member]
At fair value [member]
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Customers over 10% of revenue
Major Customers [member]
Customers [member]
Share price of investee shares
Share price of investee shares
Share price of investee shares
Contact Personnel Name
Contact Personnel Name
Risk-free interest rate
Risk free interest rate, share options granted
Cash investment in Associate
Cash investment in Associate
Cash investment in Associate
Weighted average assumptions [Abstract]
Share-based payment - Weighted average assumptions
Entity File Number
Entity File Number
Total Business Or Sourcing Company [Member]
Total Business Or Sourcing Company [Member]
Total Business Or Sourcing Company
Series A-1 Preferred [Member]
Series A-1 Preferred [Member]
Series A-1 Preferred
US treasuries [member]
Loans to government [member]
Number Of Shares Held
Number Of Shares Held
Number Of Shares Held
Additions, net of transfers
Additions other than through business combinations, property, plant and equipment
Level 3 of fair value hierarchy [member]
Level 3 of fair value hierarchy [member]
Conversion to common
Conversion to common
Conversion to common
Finance Cost, net
Disclosure of finance cost [text block]
Disclosure of associates [Line Items]
Disclosure of associates [Line Items]
Disclosure of associates
Consideration for acquired non-controlling interest
Consideration for acquired non-controlling interest
Consideration for acquired non-controlling interest
Disclosure of information about employees
Disclosure of information about employees [text block]
Dr John LaMattina (individually)
Dr John LaMattina (individually) [Member]
Dr John LaMattina (individually)
Significant Subsidiary Plans [Line Items]
Significant Subsidiary Plans [Line Items]
Significant Subsidiary Plans [Line Items]
Stock Options [Member]
Stock Options [Member]
Stock Options
Related Party Transactions - Key Management Personnel Compensation [Abstract]
Related Party Transactions - Key Management Personnel Compensation
Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity
Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity
Operating Expenses [Table]
Operating Expenses [Table]
Operating Expenses [Table]
Commitments And Contingencies [Abstract]
Commitments And Contingencies [Abstract]
Gross Principal
Gross Principal
Gross Principal
Reclassification of equity settled awards to liability awards
Increase Decrease in reclassification of equity settled awards into liability awards
Increase Decrease in reclassification of equity settled awards into liability awards
Share of net (income)/loss of associates accounted for using the equity method
Adjustments for undistributed profits of investments accounted for using equity method
Share price at grant date
Weighted average share price, share options granted
Disclosure of detailed information about property, plant and equipment
Disclosure of detailed information about property, plant and equipment [text block]
Classes of intangible assets other than goodwill [axis]
Classes of intangible assets other than goodwill [axis]
Disclosure of Lease Liabilities
Disclosure of Lease Liabilities [Text Block]
Disclosure of Lease Liabilities
Total finance income/(costs)
Total Finance Income Cost
Total Finance Income Cost
Disclosure of estimated useful life of assets
Disclosure of estimated useful life of assets [Text Block]
Disclosure of estimated useful life of assets
Finance income/(costs) – fair value accounting
Rate of finance income costs - fair value accounting, reconciliation of effective tax rate
Rate of finance income costs - fair value accounting, reconciliation of effective tax rate
Audit of financial statements of associates
Audit of financial statements of associates
Audit of financial statements of associates
Total Lease Receivable
Finance lease receivables
Karuna Therapeutics, Inc.
Karuna [Member]
Karuna [Member]
Karuna
Retained earnings/ (accumulated deficit) [member]
Retained earnings [member]
Expected volatility
Expected volatility, share options granted
More than five years
Later than five years [member]
Earnings Category Axis [Axis]
Earnings Category [Axis]
Earnings Category
Other current liabilities
Other current liabilities
Disclosure of Subsidiary Share-based Payments
Disclosure of Subsidiary Share-based Payment Plans [Text Block]
Disclosure of Subsidiary Share-based Payment Plans
Provisions
Description of accounting policy for provisions [text block]
Classes of assets [axis]
Classes of assets [axis]
Vesting of restricted stock units (RSU)
Increase Decrease through vesting of RSU, equity
Increase Decrease through vesting of RSU, equity
Reclassification of investment to investment in associate
Reclassification of investment to investment in associate
Reclassification of investment to investment in associate
Non-controlling interests
Profit (loss), attributable to non-controlling interests
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [line items]
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [line items]
Weighted Average Options exercised [Table]
Weighted Average Options exercised [Table]
Weighted Average Options exercised
Share-based payment arrangement, cash settlement value
Share-based Payment Arrangement, Cash Used to Settle Award
Share-based Payment Arrangement, Cash Used to Settle Award
Capital and Financial Risk Management
Disclosure of financial risk management [text block]
Statement of changes in equity [line items]
Statement of changes in equity [line items]
Current assets
Current assets [abstract]
Share based liabilty awards
Share based liabilty awards [Member]
Share based liabilty awards
Gain on loss of significant influence
Gain/(Loss) on loss of significant influence
Gain/(Loss) on loss of significant influence
Karuna Therapeutics, Inc. [Member]
Karuna Therapeutics, Inc. [Member]
Karuna Therapeutics, Inc.
State [Member]
State [Member]
State
(Gain)/loss on investments held at fair value
Adjustments for fair value losses (gains)
Lease liability, non-current
Long-term Portion of Lease Liability
Non-current lease liabilities
Business combination, number of shares received for additional cost
Business Combination, Number of Shares received for additional cost
Business Combination, Number of Shares received for additional cost
Expected dividend yield
Expected dividend, share options granted
Number of associate's common stock held at fair value
Number of associate common stock held at fair value
Number of associate common stock held at fair value
Research And Development [Member]
Research And Development [Member]
Research And Development
Series A-3 Preferred [Member]
Series A-3 Preferred [Member]
Series A-3 Preferred
US federal statutory rate
Tax expense (income) at applicable tax rate
Consideration for acquired non-controlling interest, second installment
Consideration for acquired non-controlling interest, second installment
Consideration for acquired non-controlling interest, second installment
Other reserves
Other reserves
Significant Subsidiary Plans [Abstract]
Significant Subsidiary Plans [Abstract]
Significant Subsidiary Plans
Entity's total for segment consolidation items [member]
Entity's total for segment consolidation items [member]
Types of customers [member]
Types of customers [member]
Deferred revenue
Deferred revenue [Member]
Deferred revenue
Finance income/(costs):
Finance income/(costs) [Abstract]
Finance income/(costs)
Sale of equity instruments in other entities
Sale of equity instruments in other entities
Sale of equity instruments in other entities
Commitments and Contingencies [Table]
Commitments and Contingencies [Table]
Commitments and Contingencies
LiabilitiesFromSharebasedPaymentTransactions, performance and market conditions met
LiabilitiesFromSharebasedPaymentTransactions, performance and market conditions met
LiabilitiesFromSharebasedPaymentTransactions, performance and market conditions met
Vedanta Biosciences, Inc.
Vedanta Biosciences
Vedanta Biosciences [Member]
Vedanta Biosciences
Increase (decrease) through conversion of convertible instruments, equity
Increase (decrease) through conversion of convertible instruments, equity
Valuation techniques [member]
Valuation techniques [member]
Current year losses for which no deferred tax asset is recognized
Tax rate effect of tax losses
Cash flows from financing activities:
Cash flows from (used in) financing activities [abstract]
Other
Other tax rate effects for reconciliation between accounting profit and tax expense (income)
Total income tax expense/(benefit), recognized
Deferred tax expense (income) recognised in profit or loss
Disclosure of detailed information about borrowings [line items]
Disclosure of detailed information about borrowings [line items]
Neither past due nor impaired [Abstract]
Trade and other receivables not impaired [Abstract]
Trade and other receivables not impaired
Disclosure of Other Financial Assets
Other Financial Assets [Text Block]
Other Financial Assets
Performance based RSU [Member]
Performance based RSU [Member]
Performance based RSU
Laboratory and manufacturing equipment
Laboratory and Manufacturing Equipment [Member]
Laboratory and Manufacturing Equipment
Total other comprehensive income/(loss)
Other comprehensive income/(loss)
Other comprehensive income
Disclosure of financial liabilities - Warrants, weighted-average assumptions
Disclosure of financial liabilities - Warrants, weighted-average assumptions [Text Block]
Disclosure of financial liabilities - Warrants, weighted-average assumptions
Outstanding (Non-vested), beginning of year (in shares)
Outstanding (Non-vested), end of year (in shares)
Number of other equity instruments outstanding in share-based payment arrangement
Disclosure of quantitative information about right-of-use assets [table]
Disclosure of quantitative information about right-of-use assets [table]
Lease liability, current
Short-term Portion of Lease Liability
Current lease liabilities
Unobservable inputs [member]
Unobservable inputs [member]
Interest rate types [member]
Interest rate types [member]
Outstanding at beginning of period
Outstanding at end of period
Number of share options
Number of share options outstanding in share-based payment arrangement
Average effective tax rate
Average effective tax rate
Trade and other receivables not impaired [Table]
Trade and other receivables not impaired [Table]
Neither Past due or impaired [Table]
Capital And Financial Risk Management [Abstract]
Capital And Financial Risk Management
Weighted-average exercise price, beginning of year (GBP)
Weighted-average exercise price, end of year (GBP)
Wtd Average Exercise Price (GBP)
Weighted-average exercise price $
Weighted average exercise price of share options outstanding in share-based payment arrangement
Impairment of investment in associate
Impairment loss recognised in profit or loss
Purchase of property and equipment
Purchase of property, plant and equipment, classified as investing activities
Other
Other inflows (outflows) of cash, classified as operating activities
Not later than 10 years
Not later than 10 years [Member]
Not later than 10 years
Par value per share
Par value per share
Purchase of subsidiary non-controlling interest through issuance of shares (in shares)
Increase Decrease through purchase of subsidiary non-controlling interest through issuance of shares
Increase Decrease through purchase of subsidiary non-controlling interest through issuance of shares
Akili Interactive Labs, Inc.
Akili Interactive Labs [Member]
Akili Interactive Labs
Cash derecognized upon loss of control over subsidiary
Cash flows from losing control of subsidiaries or other businesses, classified as investing activities
2022
Less than one year
Not later than one year [member]
Financial liabilities
Financial liabilities
Tax Credits
Tax credits expiring
Unused tax credits for which no deferred tax asset recognised
Total assets
Total assets
Assets
Entity's total for related parties [member]
Entity's total for related parties [member]
Basic earnings (loss) per share
Basic earnings (loss) per share
Accumulated depreciation and impairment loss
Accumulated depreciation, amortisation and impairment [member]
Total Income Tax Type [Member]
Total Income Tax Type [Member]
Total Income Tax Type
PureTech LYT-100
PureTech LYT - 100 [Member]
PureTech LYT - 100
Computer equipment and software
Computer equipment [member]
Operating income/(loss)
Profit (loss) from operating activities
Payments in respect of developmental milestones, dependent on events outside control of company, but reasonably possible to occur
Estimated financial effect of contingent liabilities
Disclosure of Subsidiary preferred shares, Minimum liquidation preference
Summary of Minimum liquidation preference [Text Block]
Summary of Minimum liquidation preference
Research and development expenses
Research and development expense
Customer D
Customer D [Member]
Customer D
Current year losses for which no deferred tax asset is recognized
Tax effect of tax losses
Share-based Payment [Line Items]
Share-based Payment [Line Items]
Share-based Payment
Purchases of short-term investments
Purchase of financial instruments, classified as investing activities
Accrued interest - contractual
Accrued interest - contractual
Accrued interest - contractual
Balance at beginning of period before allocation of associate loss to long-term interest
Balance at end of period before allocation of associate loss to long-term interest
Financial assets, at fair value
Financial assets
Financial assets, at fair value
Exercise of share-based awards (in shares)
Effect of shares issued
Increase (decrease) in number of ordinary shares issued
Finance income/(costs) – subsidiary preferred shares
Total finance costs – subsidiary preferred shares
Finance income/(costs) - subsidiary preferred shares
Finance income/(costs) - subsidiary preferred shares
Equity settled share-based awards
Increase (decrease) through share-based payment transactions, equity
Other income/(expense)
Other income
Disclosure of detailed information about borrowings [abstract]
Disclosure of detailed information about borrowings [abstract]
Series C-2 Preferred [Member]
Series C-2 Preferred [Member]
Series C-2 Preferred
Diluted [Member]
Diluted [Member]
Diluted
Weighted Average Options exercisable [Abstract]
Weighted Average Options exercisable [Abstract]
Weighted Average Options exercisable
Issue of convertible instruments
Issue of convertible instruments
Disclosure of information of employees [Table]
Disclosure of information of employees [Table]
Disclosure of information of employees [Table]
Accrued interest
Borrowings, Accrued Interest
Borrowings, Accrued Interest
Disclosure of Earnings/(Loss) per Share
Schedule of Earnings per Share [Text Block]
Schedule of Earnings per Share
Consolidated Statements of Financial Position
Statement of financial position [abstract]
Minimum
Minimum [Member]
Non-adjusting events after reporting period [member]
Non-adjusting events after reporting period [member]
Income – DCF & OPM allocation
Income approach [member]
Licences [member]
Licences [member]
Total Operating Expense [Member]
Total Operating Expense [Member]
Total Operating Expense
Gain/(loss) on investments held at fair value
Gain/(Loss) on changes in fair value
Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, assets
Other financial assets
Restricted cash
Restricted cash and cash equivalents
Classes of financial assets [axis]
Classes of financial assets [axis]
Issued ordinary shares at January 1,
Number of shares outstanding
Convertible Notes [Roll Forward]
Convertible Notes [Roll Forward]
Convertible Notes
Consideration paid (received)
Consideration paid (received)
Liability settled share based awards
Other payables, liability settled share based awards
Other payables, liability settled share based awards
Disclosure of stock option activity
Disclosure of number and weighted average exercise prices of share options [text block]
Short-term note from associate
Current receivables due from associates
Subsidiaries with material non-controlling interests [member]
Subsidiaries with material non-controlling interests [member]
Weighted Average
Warrants
Significant unobservable input, liabilities
Gain on loss of significant influence
Adjustments for gain on loss of significant influence
Adjustments for gain on loss of significant influence
Expiring [Axis]
Expiring [Axis]
Expiring
Convertible instruments, discount rate
Convertible instruments, discount rate
Convertible instruments, discount rate
Disclosure of detailed information about property, plant and equipment [abstract]
Right of use asset, net
Balance at beginning of period
Balance at end of period
Right-of-use assets
Share-based Compensation Arrangement by Share-based Payment Award, Shares Remaining Available For Issuance
Share-based Compensation Arrangement by Share-based Payment Award, Shares Remaining Available For Issuance
Share-based Compensation Arrangement by Share-based Payment Award, Shares Remaining Available For Issuance
Significant Subsidiary Plan [Line Items]
Significant Subsidiary Plan [Line Items]
Significant Subsidiary Plan
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets [table]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets [table]
Intangible Assets
Description of accounting policy for intangible assets other than goodwill [text block]
PureTech Health LLC
PureTech Health LLC
PureTech Health [Member]
PureTech Health
Taxation
Income tax expense/(benefit)
Income tax expense/(benefit)
Tax expense (income)
Stock committed to acquire during period, price per share
Stock Committed To Acquire During Period, Price Per Share
Stock Committed To Acquire During Period, Price Per Share
Loss realized on sale of investments
Losses on disposals of investments
Aggregated time bands [member]
Aggregated time bands [member]
Entity Emerging Growth Company
Entity Emerging Growth Company
Disclosure of associates [table]
Disclosure of associates [table]
Notes payable
Notes and debentures issued
Vesting of share-based awards and net share exercise
Increase Decrease through vesting of share based awards and net share exercise, equity
Increase Decrease through vesting of share based awards and net share exercise, equity
Directors [Abstract]
Directors [Abstract]
Directors
Non-current liabilities
Non-current liabilities [abstract]
Liquidity Risk [Table]
Liquidity Risk [Table]
Liquidity Risk [Table]
Capital And Financial Risk Management [Table]
Capital And Financial Risk Management [Table]
Capital And Financial Risk Management
Disclosure of disaggregation of revenue from contracts with customers
Disclosure of disaggregation of revenue from contracts with customers [text block]
Auditor Name
Auditor Name
Cover [Abstract]
Measurement [axis]
Measurement [axis]
Disclosure of maturity analysis of operating lease payments [line items]
Disclosure of maturity analysis of operating lease payments [line items]
Cash flows from investing activities:
Cash flows from (used in) investing activities [abstract]
Weighted Average Options Outstanding [Line Items]
Weighted Average Options Outstanding [Line Items]
Weighted Average Options Outstanding
Current liabilities
Current liabilities [abstract]
Revenue [abstract]
Revenue [abstract]
Acquisition of a non-controlling Interest of a subsidiary
Payments from changes in ownership interests in subsidiaries that do not result in loss of control
Other non-current assets
Other non-current assets
Operating expenses:
Operating Expenses [Abstract]
Operating Expenses
Total other operating expenses
Miscellaneous other operating expense
Trade and other payables
Trade and other payables [Member]
Trade and other payables
Schedule of Trade And Other Payables
Schedule of Trade And Other Payables [Text Block]
Schedule of Trade And Other Payables
Disclosure of financial assets [line items]
Disclosure of financial assets [line items]
Deferred tax assets
Deferred tax assets
Entity's total for subsidiaries [member]
Entity's total for subsidiaries [member]
Disclosure of Share-based Payment Expense Table
Share-based Payment Expense Table [Text Block]
Share-based Payment Expense Table
Non deductible share based payment expenses
Share based Payment expenses, non-deductible, reconciliation of effective tax rate
Share based Payment expenses, non-deductible, reconciliation of effective tax rate
Operating Loss Carryforwards, Expiration Periods [Axis]
Operating Loss Carryforwards, Expiration Periods [Axis]
Operating Loss Carryforwards, Expiration Periods
Vesting of restricted stock units
Vesting of restricted stock units
Vesting of restricted stock units
Liability for share based awards
Non current Liabilities From Share based Payment Transactions
Non current Liabilities From Share based Payment Transactions
Document and Entity Information [Table]
Document Information [Table]
Weighted average exercise price, options exercised (GBP)
Weighted-average exercise price $
Weighted average exercise price of share options exercised in share-based payment arrangement
Repayments of non-current borrowings
Repayments of non-current borrowings
Accounting Policies - Property and Equipment [Table]
Accounting Policies - Property and Equipment [Table]
Accounting Policies - Property and Equipment [Table]
Revenue [Table]
Revenue [Table]
Revenue
Leases
Disclosure of leases [text block]
Warrant liability
Current derivative financial liabilities
Market/Asset – PWERM & Hybrid allocation
Market – PWERM & Hybrid allocation
Market, PWERM and Hybrid allocation [Member]
Market, PWERM and Hybrid allocation
Long-term loan [Member]
Long-term loan [Member]
Long-term loan
Exercise of share-based awards
Increase (decrease) through exercise of options, equity
Level 2 of fair value hierarchy [member]
Level 2 of fair value hierarchy [member]
Entrega, Inc. (indirectly held through Enlight)
Entrega
Entrega [Member]
Entrega
Audit of these financial statements
Auditor's remuneration for audit services
Financial Asset Increase/ (Decrease)
Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets
Market – Backsolve & OPM allocation
Market, Backsolve and OPM allocation [Member]
Market, Backsolve and OPM allocation
Vedanta Biosciences Securities Corp. (indirectly held through Vedanta)
Vedanta Biosciences Securities Corp [Member]
Vedanta Biosciences Securities Corp
Share-Based Payment Arrangements [Abstract]
Share-Based Payment Arrangements [Abstract]
Disclosure of Payroll Costs
Disclosure of Payroll Costs [Text Block]
Disclosure of Payroll Costs
Finance costs, net
Adjustments for finance costs
Floating interest rate [member]
Floating interest rate [member]
Prepaid expenses
Current prepaid expenses
Changes in operating assets and liabilities:
Changes in operating assets and liabilities [Abstract]
Changes in operating assets and liabilities
Cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Cash and cash equivalents
Major business combination [member]
Major business combination [member]
Weighted Average number of ordinary shares [Line Items]
Weighted Average number of ordinary shares [Line Items]
Weighted Average number of ordinary shares
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]
Retained earnings/(accumulated deficit)
Retained earnings
Reclassification from level 3 to level 1
Reclassification from level 3 to level 1
Reclassification from level 3 to level 1
Expected terms (in years)
Option life, share options granted
Summary Of investments held at fair value
Summary Of investments held at fair value [Text Block]
Summary Of investments held at fair value
Property and equipment, net
Balance at beginning of period
Balance at end of period
Property, plant and equipment
Notes Payable [Table]
Notes Payable [Table]
Notes Payable
Non-audit related services
Auditor's remuneration for other services
Recurring fair value measurement [member]
Recurring fair value measurement [member]
Weighted average number of ordinary shareholders at December 31,
Weighted average number of ordinary shares used in calculating diluted earnings per share
Other
Other
Other
Share-based Compensation Arrangement by Share-based Payment Award, Shares Approved For Issuance
Share-based Compensation Arrangement by Share-based Payment Award, Shares Approved For Issuance
Share-based Compensation Arrangement by Share-based Payment Award, Shares Approved For Issuance
Intangible Assets
Disclosure of intangible assets [text block]
Disclosure of Weighted Average Exercise Prices for Options Forfeited
Disclosure of Weighted Average Exercise Prices for Options Forfeited [Text Block]
Disclosure of Weighted Average Exercise Prices for Options Forfeited
Value at Issuance
Warrant Issuance
Value at Issuance
Value at Issuance
Lease receivable – short-term
Short-term Portion of Lease Receivable
Current finance lease receivables
Segment consolidation items [axis]
Segment consolidation items [axis]
Investments held at fair value
Disclosure Of Investments held at fair value [Text Block]
Disclosure Of Investments held at fair value
Net cash provided by financing activities
Cash flows from (used in) financing activities
Non-controlling interests
Non-controlling interests
Disclosure of Weighted Average Exercise Prices for Options Granted
Disclosure of Weighted Average Exercise Prices for Options Granted [Text Block]
Disclosure of Weighted Average Exercise Prices for Options Granted
Preferred shares
Subsidiary Preferred Shares
Beginning balance
Ending balance
Preferred Share Liability
Preferred Share Liability
Available indefinitely
Available indefinitely [Member]
Available indefinitely
Balance at beginning of period
Balance at end of period
Financial liabilities, at fair value
Financial liabilities
Financial liabilities, at fair value
Entity Address, City or Town
Entity Address, City or Town
Investments in Associates
Disclosure of associates [text block]
All levels of fair value hierarchy [member]
All levels of fair value hierarchy [member]
Disclosure of interests in Subsidiaries [Table]
Disclosure of interests in Subsidiaries [Table]
Disclosure of interests in Subsidiaries [Table]
Sensitivity Range
Percentage of reasonably possible increase in unobservable input, liabilities
Common shares [member]
Ordinary shares [member]
Directors and Senior Managers Shareholdings and Share Incentive awards [Line Items]
Directors and Senior Managers Shareholdings and Share Incentive awards [Line Items]
Directors and Senior Managers Shareholdings and Share Incentive awards
Oxford Finance LLC
Oxford Finance LLC [Member]
Oxford Finance LLC
Loans
Loans [Member]
Loans
Disclosure of financial liabilities [abstract]
Group's share of total comprehensive income (loss) - limited to net investment amount
Share of total comprehensive income of associates and joint ventures accounted for using equity method
Alivio Therapeutics, Inc.
Alivio [Member]
Alivio [Member]
Alivio
Disclosure of Weighted Average Exercise Prices for Options Exercised
Disclosure of Weighted Average Exercise Prices for Options Exercised [Text Block]
Disclosure of Weighted Average Exercise Prices for Options Exercised
MASSACHUSETTS
MASSACHUSETTS
Auditors Remuneration [Table]
Auditors Remuneration [Table]
Auditors Remuneration
Income taxes, net
Adjustments for income tax expense
Investments in associates accounted for using equity method
Investments in associates accounted for using equity method
Issued capital [member]
Issued capital [member]
Income tax receivable
Current tax assets, current
Temporary difference, unused tax losses and unused tax credits [member]
Temporary difference, unused tax losses and unused tax credits [member]
Finance income/(costs) – fair value accounting
Finance income costs - fair value accounting, reconciliation of effective tax rate
Finance income costs - fair value accounting, reconciliation of effective tax rate
Income/(Loss) for the year
Net income/(loss)
Income/(loss) for the year
Profit (loss)
Knode Inc. (indirectly held through Enlight)
Knode
Knode [Member]
Knode
Entity Filer Category
Entity Filer Category
Akili [Member]
Akili [Member]
Akili
Accounting policies, changes in accounting estimates and errors [Abstract]
Accounting Policies [Abstract]
Accounting Policies
Financial Liabilities
Description of accounting policy for financial liabilities [text block]
Dr Joseph Bolen
Dr Joseph Bolen [Member]
Dr Joseph Bolen
Three to Twelve months
Later than three months and not later than one year [member]
3.00 to 4.00
Exercise Price Range Four [Member]
Exercise Price Range Four [Member]
Purchase of intangible asset and investment held at fair value in consideration for issuance of warrant liability and assumption of other long and short-term liabilities
purchase of intangible asset and investment in consideration for issuance of warrant and other liability
purchase of intangible asset and investment in consideration for issuance of warrant and other liability
Disclosure of quantitative information about right-of-use assets
Disclosure of quantitative information about right-of-use assets [text block]
Share-based payment arrangements [member]
Share-based payment arrangements [member]
Business Combination, Investment In Common Share, Additional Investment
Business Combination, Investment In Common Share, Additional Investment
Business Combination, Investment In Common Share, Additional Investment
Amendment Flag
Amendment Flag
Receipt of payment of sublease
Receipt of payment of sublease
Receipt of payment of sublease
Basis of Measurement
Explanation of measurement bases used in preparing financial statements [text block]
Weighted average exercise price, options granted (GBP)
Weighted average exercise price
Weighted average exercise price of share options granted in share-based payment arrangement
Proportion of ownership interest in associate
Proportion of ownership interest in associate
Share of associate loss allocated to long-term interest
Share of associate loss allocated to long-term interest
Share of associate loss allocated to long-term interest
Accrued interest, Convertible Notes
Accrued interest, Convertible Notes
Accrued interest, Convertible Notes
Amortization of ROU assets
Depreciation
Depreciation, right-of-use assets
Financial Instruments
Disclosure of financial instruments [text block]
Trade and Other Payables
Disclosure of trade and other payables [text block]
Balance at end of period after allocation of associate loss to long-term interest
Financial Assets At Fair Value Through Profit Or Loss after allocation to long-term interest
Financial Assets At Fair Value Through Profit Or Loss after allocation to long-term interest
Ownership Interest
Ownership Interest
Ownership Interest
Non-adjusting events after reporting period [axis]
Non-adjusting events after reporting period [axis]
Earnings/(Loss) attributable to owners of the Company [Table]
Earnings/(Loss) attributable to owners of the Company [Table]
Earnings/(Loss) attributable to owners of the Company
Total current income tax expense/(benefit)
Current tax expense (income)
Issuance of note receivable
Issuance of note receivable
Issuance of note receivable
Total
Auditor's remuneration
Ranges of exercise prices for outstanding share options [member]
Ranges of exercise prices for outstanding share options [member]
Non-controlling interests
Comprehensive income, attributable to non-controlling interests
Changes in the value of subsidiary preferred shares [Abstract]
Changes in the value of subsidiary preferred shares [Abstract]
Changes in the value of subsidiary preferred shares
Related party transactions [Line Items]
Related party transactions [Line Items]
Related party transactions
Preference shares [member]
Preference shares [member]
Balance Share Capital (in shares)
Balance Share Capital (in shares)
Number of shares issued
Number of shares issued
Proceeds from issue of convertible notes
Proceeds from issue of convertible notes
Proceeds from issue of convertible notes
Gain on deconsolidation [Table]
Gain on deconsolidation [Table]
Gain on deconsolidation
Ms Dapne Zohar
Ms Dapne Zohar [Member]
Ms Dapne Zohar
Deferred Tax Assets and Liabilities [Table]
Deferred Tax Assets and Liabilities [Table]
Deferred Tax Assets and Liabilities [Table]
Realized loss on sale of investments
Adjustments for losses (gains) on disposal of non-current assets
Disclosure of Maturity Analysis of Operating Lease Payments [Table]
Disclosure of maturity analysis of operating lease payments [table]
Interest received
Interest received, classified as operating activities
Dr John LaMattina
Dr John LaMattina [Member]
Dr John LaMattina
Business combination, available funds threshold
Business Combination, Available Funds Threshold
Business Combination, Available Funds Threshold
Total non-current liabilities
Non-current liabilities
Non-current liabilities
Related Parties Transactions
Disclosure of transactions between related parties [text block]
Interest income from financial assets
Interest income for financial assets not at fair value through profit or loss
One year to Five Years
Later than one year and not later than five years [member]
Fair Value Measurements
Description of accounting policy for fair value measurement [text block]
Proportion of ownership interests held by non-controlling interests
Proportion of ownership interests held by non-controlling interests
Performance obligations [member]
Performance obligations [member]
Excess of fair value at reclassification date over grant date fair value
Excess of fair value at reclassification date over grant date fair value
Excess of fair value at reclassification date over grant date fair value
Payables to related parties
Payables to related parties
Purchases of intangible assets
Purchase of intangible assets, classified as investing activities
Related party transactions [abstract]
Related party transactions [abstract]
Subsidiary Enterprise Value
Investee Enterprise Value
Subsidiary Enterprise Value [Member]
Subsidiary Enterprise Value
Segment Information
Disclosure of entity's operating segments [text block]
Other comprehensive income/(loss):
Other comprehensive income [abstract]
RSU [Table]
RSU [Table]
RSU
Federal [Member]
Federal [Member]
Federal
Document Annual Report
Document Annual Report
Business combination, number of additional shares received at no additional cost
Business Combination, Number Of Additional Shares Received At No Additional Cost
Business Combination, Number Of Additional Shares Received At No Additional Cost
Proportion of ownership interest in investee
Proportion of ownership interest in investee
Proportion of ownership interest in investee
Interest
Interest On Undiscounted Lease payments
Interest On Undiscounted Lease payments
NCI exercise of share-based awards in subsidiaries
Increase Decrease Through NCI exercise of share-based awards in Subsidiaries
Increase Decrease Through NCI exercise of share-based awards in Subsidiaries
Follica, Incorporated
Follica
Follica [Member]
Follica
Contributed By - Types [Axis]
Contributed By - Types [Axis]
Contributed By - Types
Convertible debt, instruments, converted to equity
Convertible Debt, Instruments, Converted To Equity
Convertible Debt, Instruments, Converted To Equity
Transaction Costs
Rate of transaction costs, reconciliation of effective tax rate
Rate of transaction costs, reconciliation of effective tax rate
Other
Other current payables
Segments [member]
Segments [member]
Investment upon initial public offering
Investment upon initial public offering
Investment upon initial public offering
Parent Company And Other
Parent Company And Other [Member]
Parent Company And Other
Forfeited (in shares)
Number of other equity instruments forfeited in share-based payment arrangement
Classes of share capital [axis]
Classes of share capital [axis]
Taxation [Abstract]
Taxation [Abstract]
Taxation [Abstract]
Additional number of shares authorized to purchase
Additional number of shares authorized to purchase
Additional number of shares authorized to purchase
Money Markets [member]
Loans to corporate entities [member]
Business combination, additional shares to be received at no additional cost, transaction cost
Business Combination, Additional Shares To Be Received At No Additional Cost, Transaction Price
Business Combination, Additional Shares To Be Received At No Additional Cost, Transaction Price
Operating Segments
Description of accounting policy for segment reporting [text block]
Deferred tax assets and liabilities [abstract]
Sensitivity Range
Percentage of reasonably possible decrease in unobservable input, assets
Audit related assurance services
Audit related assurance services
Audit related assurance services
Subsidiary warrant liability
Warrants [Member]
Subsidiary warrant liability [Member]
Subsidiary warrant liability
Number of shares issuable based on service conditions
Number of shares issuable based on service conditions
Number of shares issuable based on service conditions
Recognition of deferred tax assets and tax benefits not previously recognized
Deferred tax assets and benefits not previously recognised, reconciliation of effective tax rate
Deferred tax assets and benefits not previously recognised, reconciliation of effective tax rate
Exercise price
Exercise price
Exercise price
Percentage vote and value of subsidiaries in the Group consolidated state tax return
Percentage vote and value of subsidiaries in the Group consolidated state tax return
Percentage vote and value of subsidiaries in the Group consolidated state tax return
Trade payables
Current trade payables
Earnings/(Loss) attributable to owners of the Company [Line Items]
Earnings/(Loss) attributable to owners of the Company [Line Items]
Earnings/(Loss) attributable to owners of the Company
Short-term note [Table]
Short-term note [Table]
Short-term note [Table]
Settlement of restricted stock units
Increase decrease through settlement of restricted stock units
Increase decrease through settlement of restricted stock units
Number of shares issued by investee
Number of shares issued by investee
Number of shares issued by investee
Issuance of subsidiary preferred Shares
Proceeds from issue of preference shares
Ranges [member]
Ranges [member]
Equity
Equity [abstract]
Business Or Sourcing Company [Axis]
Business Or Sourcing Company [Axis]
Business Or Sourcing Company
Impairment of financial assets [axis]
Impairment of financial assets [axis]
Vested (in shares)
Number of other equity instruments exercised or vested in share-based payment arrangement
Share of profit (loss) from continuing operations of associates and joint ventures accounted for using equity method
Group's share in net income (losses) - limited to net investment amount
Share of profit (loss) from continuing operations of associates and joint ventures accounted for using equity method
Disclosure of Weighted Average Exercise Prices for Options Exercisable
Disclosure of Weighted Average Exercise Prices for Options Exercisable [Text Block]
Disclosure of Weighted Average Exercise Prices for Options Exercisable
Number of shares on conversion from notes
Number of shares on conversion from notes
Number of shares on conversion from notes
Performance obligations [axis]
Performance obligations [axis]
Discount, conversion from notes - qualified financing
Discount, conversion from notes - qualified financing
Discount, conversion from notes - qualified financing
Long-term loan
Beginning balance
Ending balance
Total Long-term loan
Borrowings
Share of associate loss recorded to long-term interest
Share of associate loss recorded against long-term interest
Share of associate loss recorded against long-term interest
Weighted Average Options exercisable [Line Items]
Weighted Average Options exercisable [Line Items]
Weighted Average Options exercisable
Contributed By [Member]
Contributed By [Member]
Contributed By
Disclosure of detailed information about borrowings [table]
Disclosure of detailed information about borrowings [table]
Disclosure of detailed information about intangible assets [abstract]
Investments held at fair value [Abstract]
Investments held at fair value [Abstract]
Total comprehensive income/(loss) for the year
Share of comprehensive income (loss)
Total comprehensive income/(loss) for the year
Comprehensive income
Tal Medical, Inc.
Tal [Member]
Tal
Internal
Internal [Member]
Internal
Employee Benefits
Description of accounting policy for employee benefits [text block]
Total Subsidiary Types [Member]
Total Subsidiary Types [Member]
Total Subsidiary Types
Estimated time to exit
Estimated time to exit, measurement input [Member]
Estimated time to exit, measurement input
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [table]
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [table]
Total other financial assets
Other financial assets
Disaggregation of Revenue - Customers over 10% of revenue [Table]
Disaggregation of Revenue - Customers over 10% of revenue [Table]
Disaggregation of Revenue - Customers over 10% of revenue
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [table]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [table]
Valuation techniques used in fair value measurement [axis]
Valuation techniques used in fair value measurement [axis]
Foreign Currency
Description of accounting policy for foreign currency translation [text block]
Lease receivable – long-term
Long-term Portion of Lease Receivable
Non-current finance lease receivables
Contract revenue
Revenue from contracts with customers
General and administrative expenses
General and administrative expense
Entity Central Index Key
Entity Central Index Key
Level 1 of fair value hierarchy [member]
Level 1 of fair value hierarchy [member]
Sonde Health, Inc.
Sonde
Sonde [Member]
Sonde
Lease Liabilities [Table]
Lease Liabilities [Table]
Lease Liabilities [Table]
Endra Holdings, LLC (held indirectly through Enlight)
Endra Holdings LLC [Member]
Endra Holdings LLC
Amortization
Amortisation, intangible assets other than goodwill
Performance Share Plan [Member]
Performance Share Plan [Member]
Performance Share Plan
Nontrading holding companies
Nontrading holding companies [Abstract]
Nontrading holding companies
Types of interest rates [axis]
Types of interest rates [axis]
Directors and Senior Managers Shareholdings and Share Incentive awards [Abstract]
Directors and Senior Managers Shareholdings and Share Incentive awards [Abstract]
Directors and Senior Managers Shareholdings and Share Incentive awards
Unused Federal orphan drug tax credits
Unused Federal orphan drug tax credits
Unused Federal orphan drug tax credits
Issued Share capital acquired
Issued Share capital acquired
Issued Share capital acquired
Directors’ and Senior Managers’ Shareholdings and Share Incentive Awards
Disclosure Of Information About Shareholdings of Key Management Personnel Explanatory [Text Block]
Disclosure Of Information About Shareholdings of Key Management Personnel Explanatory
Associates
Description of accounting policy for investment in associates [text block]
Disclosure of terms and conditions of share-based payment arrangement [table]
Disclosure of terms and conditions of share-based payment arrangement [table]
Interest income
Interest income
Subsidiary Preferred Shares Balances [Table]
Subsidiary Preferred Shares Balances [Table]
Subsidiary Preferred Shares Balances [Table]
Subsidiary note conversion and changes in NCI ownership interest
Subsidiary note conversion and changes in NCI ownership interest
Subsidiary note conversion and changes in NCI ownership interest
Disclosure of maturity analysis of operating lease payments [text block]
Disclosure of maturity analysis of operating lease payments [text block]
Trading Symbol
Trading Symbol
Net loan proceeds
Borrowings, Net loan proceeds
Borrowings, Net loan proceeds
Trade and other payables [abstract]
Purchase of property plant and equipment against trade and other payables
Purchase of property plant and equipment against trade and other payables
Purchase of property plant and equipment against trade and other payables
Senior Managers [Abstract]
Senior Managers [Abstract]
Senior Managers
Aggregate principal amount
Notional amount
Short-term note from associate
Short-term note from associate [Member]
Short-term note from associate
Executive Compensation
Rate of executive compensation, reconciliation of effective tax rate
Rate of executive compensation, reconciliation of effective tax rate
Ranges of exercise prices for outstanding share options [axis]
Ranges of exercise prices for outstanding share options [axis]
Subsidiary
Subsidiary [Abstract]
Subsidiary
Equity settled share-based payment expense
Adjustments for share-based payments
Development Costs
Description of accounting policy for research and development expense [text block]
Balance of accreted premium net of unamortized issuance costs
Borrowings, Discount [Member]
Borrowings, Discount
Subsidiary Plans [Line Items]
Subsidiary Plans [Line Items]
Subsidiary Plans
Sensitivity Range
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Increase In Risk Variable, Period
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Increase In Risk Variable, Period
Finance income
Total Finance income
Finance income
Subsidiary Notes Payable
Disclosure of Subsidiary Notes Payable [Text Block]
Disclosure of Subsidiary Notes Payable
Investment in Associates [Abstract]
Investment in Associates [Abstract]
Investment in Associates [Abstract]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets [line items]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets [line items]
Series D
Series D [Member]
Series D
Measurement Input, Weighted Term To Exit (in years)
Measurement Input, Weighted Term To Exit [Member]
Measurement Input, Weighted Term To Exit
Capital And Financial Risk Management [Line Items]
Capital And Financial Risk Management [Line Items]
Capital And Financial Risk Management
Disclosure of credit risk
Disclosure of credit risk [text block]
Issuance of warrants
Issuance of warrants
Issuance of warrants
Expected dividend yield
Expected dividend yield, measurement input [Member]
Expected dividend yield, measurement input
Share Capital
Description of accounting policy for issued capital [text block]
Contract Balances [Table]
Contract Balances [Table]
Contract Balances [Table]
Gain on deconsolidation
Gains (losses) recognised when control of subsidiary is lost
Total operating expense
Operating expense
Subsidiary Types [Axis]
Subsidiary Types [Axis]
Subsidiary Types
Statement of cash flows [abstract]
Weighted average grant date fair value, RSU granted (in GBP per share)
Weighted average grant date fair value of other equity instruments granted in share-based payment arrangement
Weighted average grant date fair value of other equity instruments granted in share-based payment arrangement
Recognised Income Tax Expense [Abstract]
Recognised Income Tax Expense [Abstract]
Recognised Income Tax Expense
Transaction Costs
Transaction Costs, reconciliation of effective tax rate
Transaction Costs, reconciliation of effective tax rate
Number Of Shares Held by PureTech
Number Of Shares Held by PureTech
Number Of Shares Held by PureTech
Terminal value growth rate
Terminal value growth rate, measurement input [Member]
Terminal value growth rate, measurement input
Carrying Amount
Carrying amount [member]
Tax losses and tax credits carryforwards [Table]
Tax losses and tax credits carryforwards [Table]
Tax losses and tax credits carryforwards [Table]
Non-cancellable contractual commitments
Contractual capital commitments
Categories of related parties [axis]
Categories of related parties [axis]
Loss on disposal of assets
Adjustments for gain (loss) on disposals, property, plant and equipment
Volatility
Expected volatility
Historical volatility for shares, measurement input [member]
Other
Borrowings, other
Borrowings, other
Changes in the value of subsidiary preferred shares [Roll Forward]
Changes in the value of subsidiary preferred shares [Roll Forward]
Changes in the value of subsidiary preferred shares
Subsidiary Notes Payable - Loans [Table]
Subsidiary Notes Payable - Loans [Table]
Subsidiary Notes Payable - Loans [Table]
Options exercisable (in shares)
Number of options
Number of share options exercisable in share-based payment arrangement
Income tax receivable - current
Trade receivables, income tax receivable
Trade receivables, income tax receivable
Exercise of stock options
Proceeds from exercise of options
Translation reserve [member]
Reserve of exchange differences on translation [member]
Temporary difference, unused tax losses and unused tax credits [axis]
Temporary difference, unused tax losses and unused tax credits [axis]
Weighted average number of ordinary shareholders at December 31,
Weighted average number of ordinary shares used in calculating basic earnings per share
Unrecognised share of losses of associates
Unrecognised share of losses of associates
Non controlling interests and options issued to third parties
Non controlling interests and options issued to third parties
Non controlling interests and options issued to third parties
Auditor Firm ID
Auditor Firm ID
Disclosure of Significant unobservable Inputs - Investments at Fair Value, Assets
Financial Instruments, Significant unobservable Inputs - Investments at Fair Value, Assets [Text Block]
Financial Instruments, Significant unobservable Inputs - Investments at Fair Value, Assets
Preferred share warrants
Preferred share warrants [Member]
Preferred share warrants
Notes Payable [Line Items]
Notes Payable [Line Items]
Notes Payable
Deconsolidation adjustments
Deconsolidation adjustments, reconciliation of effective tax rate
Deconsolidation adjustments, reconciliation of effective tax rate
Option pricing model [member]
Option pricing model [member]
Commitments and Contingencies
Disclosure of commitments and contingent liabilities [text block]
Subsidiary Plans [Abstract]
Subsidiary Plans [Abstract]
Subsidiary Plans
Undiscounted finance lease payments to be received
Undiscounted finance lease payments to be received
Interest Expense
Interest expense, reconciliation of effective tax rate
Interest expense, reconciliation of effective tax rate
Earnings/(loss) per share
Earnings/(loss) per share [Abstract]
Earnings/(loss) per share
Total Share-based Payments Expense Category [Member]
Total Share-based Payments Expense Category [Member]
Total Share-based Payments Expense Category
Probability Weighted Expected Return Method
Probability Weighted Expected Return Method [Member]
Probability Weighted Expected Return Method
Operating tax losses
Unused tax losses [member]
Equity
Disclosure of Equity [Text Block]
Disclosure of Equity
Components of equity [axis]
Components of equity [axis]
Short-term and Long-term of lease receivables [Table]
Short-term and Long-term of lease receivables [Table]
Short-term and Long-term of lease receivables [Table]
Taxation
Description of accounting policy for income tax [text block]
Performance Share Plan [Line Items]
Performance Share Plan [Line Items]
Performance Share Plan
Reclassification of investment at loss of significant influence
Reclassification of investment at loss of significant influence
Reclassification of investment at loss of significant influence
Summary of Financial information of Gelesis
Summary of Financial information of Gelesis [Text Block]
Summary of Financial information of Gelesis
Net assets/(liabilities)
Net assets/(liabilities)
Assets (liabilities)
Non-controlling Interest
Disclosure of non-controlling interests [text block]
Prepaid expenses for expected subsidiary IPO, Audit related assurance services
Prepaid expenses for expected subsidiary IPO, Audit related assurance services
Prepaid expenses for expected subsidiary IPO, Audit related assurance services
Comprehensive income/(loss) attributable to:
Total comprehensive income/(loss) attributable to:
Comprehensive income attributable to [abstract]
Additions
Additions Lease Liabilities
Additions Lease Liabilities
Types of share-based payment arrangements [axis]
Types of share-based payment arrangements [axis]
Disclosure of subsidiaries
Disclosure of subsidiaries [text block]
Vesting of restricted stock units (RSU)
Increase Decrease through vesting of RSU
Increase Decrease through vesting of RSU
Percentage vote and value of subsidiaries included in the Group consolidated federal tax return
Percentage vote and value of subsidiaries included in the Group consolidated federal tax return
Percentage vote and value of subsidiaries included in the Group consolidated federal tax return
Summary of changes in equity classified non-controlling ownership interests in subsidiaries
Disclosure of interests in subsidiaries [text block]
Finance income [Abstract]
Finance income [Abstract]
Finance income
Adjustments
Adjustments, lease liabilities
Adjustments, lease liabilities
Sensitivity Range
Sensitivity Range
Percentage of reasonably possible decrease in unobservable input, liabilities
Intangible assets other than goodwill [member]
Intangible assets other than goodwill [member]
Summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations
Schedule of summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations [Text Block]
Schedule of summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations
Stock Incentive Plan [Member]
Stock Incentive Plan [Member]
Stock Incentive Plan
Disclosure of Long-term loan - Vedanta
Disclosure of borrowing costs [text block]
Disposals
Disposals
Disposals, property, plant and equipment
Income tax payable
Trade and Other Payables
Trade payables, income tax payable
Trade payables, income tax payable
Other income/(expense):
Other income/(expense) [Abstract]
Other income/(expense)
Financial Instruments - Fair value Measurement and Classification [Table]
Financial Instruments - Fair value Measurement and Classification [Table]
Financial Instruments - Fair value Measurement and Classification [Table]
Risks [member]
Risks [member]
Finance Cost Net [Abstract]
Finance Cost Net [Abstract]
Disclosure of terms and conditions of share-based payment arrangement
Disclosure of terms and conditions of share-based payment arrangement [text block]